[go: up one dir, main page]

WO2000032601A2 - Process for preparing cross-bridged tetraaza macrocycles - Google Patents

Process for preparing cross-bridged tetraaza macrocycles Download PDF

Info

Publication number
WO2000032601A2
WO2000032601A2 PCT/US1999/027316 US9927316W WO0032601A2 WO 2000032601 A2 WO2000032601 A2 WO 2000032601A2 US 9927316 W US9927316 W US 9927316W WO 0032601 A2 WO0032601 A2 WO 0032601A2
Authority
WO
WIPO (PCT)
Prior art keywords
hgand
tetraaza
macrocychc
formula
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/027316
Other languages
French (fr)
Other versions
WO2000032601A3 (en
Inventor
George Douglas Ii Hiler
Christopher Mark Perkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22332328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2000032601(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to CA002348893A priority Critical patent/CA2348893A1/en
Priority to JP2000585243A priority patent/JP2002531457A/en
Priority to AU20261/00A priority patent/AU2026100A/en
Priority to EP99963923A priority patent/EP1135392A2/en
Publication of WO2000032601A2 publication Critical patent/WO2000032601A2/en
Publication of WO2000032601A3 publication Critical patent/WO2000032601A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • B01J31/181—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
    • B01J31/1815—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine
    • B01J31/182—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine comprising aliphatic or saturated rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/70—Complexes comprising metals of Group VII (VIIB) as the central metal
    • B01J2531/72—Manganese
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/90—Catalytic systems characterized by the solvent or solvent system used
    • B01J2531/96—Water

Definitions

  • the present invention relates to an improved process for preparing cross-bridged tetraaza macrocycles, said macrocycles suitable as ligands for use m preparing transition metal complexes
  • the present invention provides a process which is well suited for use in industrial and other commercial preparations of the herein described crossed-b ⁇ dged macrocycles.
  • Tetraaza macrocyclics for example, cyclam
  • Tetraaza macrocyclics have been prepared in numerous ways, however, there is a paucity of information relating to the preparation of cross-bridged tetraaza macrocyclics inter aha bis N-substituted tetraaza macrocyclics inter alia 5,12 dialkyl 1,5,8,12- tetraaza-b ⁇ cyclo[6.6.2]hexadecanes which have recently found wide applicability as ligands especially in the area of transition metal catalysts inter alia bleach catalysts.
  • WO 98/39335 Al discloses a rational procedure for preparing cross bridged macropolycychc ligands which is amenable to high yields necessary for industrial scale-up.
  • the reductive ring cleavage step which results in bicyclo bridged-ring formation utilizes a borohyd ⁇ de reducing agent.
  • This type of reducing agent can place constraints on the formulator. For example, the need to break up the amine/borohyd ⁇ de complex du ⁇ ng work-up and the proper recovery and disposal of boron waste products adds cost to the process. Also, if excess borohyd ⁇ de is needed, this requires neutralization which involves the use of acid and the evolution of large quantities of hydrogen gas.
  • a first aspect of the present invention relates to a process for preparing a tetraaza macrocychc hgand having the formula:
  • each R is independently Cj-Cg linear or branched alkyl, -(CH 2 ) x C0 2 M, and mixtures thereof, preferably both of the R units are not methyl; M is hydrogen or a salt forming cation; x is from 1 to 6; each index n is independently from 0 to 3; said process comprising the steps of a) hydrogenat g a tetraaza macrocychc hgand precursor having the formula:
  • X is an anion which provides charge neutrality, with from about 1 ppm of a transition metal hydrogenation catalyst at a pH of at least 8 to form a tetraaza macrocychc hgand; and b) optionally isolating said hgand.
  • the present invention relates to the catalytic hydrogenation of tetraaza macrocycles having the formula: wherein the covalent bond between the N-substituted quaternary ring nitrogen and the bridging carbon is broken and a cross-bridged macrocychc hgand having the formula:
  • each R is independently Cj-C 8 linear or branched alkyl, - (CH 2 ) s C0 2 M, and mixtures thereof, preferably both of the R units are not methyl; more preferably one R unit is methyl and the other R unit is selected from the group consisting of ethyl, propyl, butyl, pentyl, hexyl. and mixtures thereof; of the methyl/alkyl R unit mixtures preferably one R is methyl and the other R is ethyl or propyl.
  • a most preferred hgand consists of a unit wherein one R unit is methyl and the other R unit is ethyl.
  • a preferred gand is a macrocychc ring wherein each R unit is ethyl.
  • M is hydrogen or a salt forming cation, non-limiting examples of which are sodium, potassium, calcium, ammonium.
  • R is -(CH 2 ) x C0 2 M the index x has the value from 1 to about 6. preferably x is 1.
  • the index n defines the size of the macrocychc ring. The index n has the value of from 0 to about 3.
  • a preferred macrocychc ring has one opposite set of n indices equal to 1 and the other set of n indices equal to 0 as in the general formula: wherein R is the same as defined herein above.
  • Preferred ligands according to the present invention comprise R unit pairs which are selected from the group consisting of methyl and ethyl, di ethyl, methyl and propyl, ethyl and propyl, methyl and butyl, ethyl and butyl, and mixtures thereof.
  • the starting materials for the process of the present invention are tetraaza macrocychc hgand precursors, or alternatively, bis-quaternary as tetracycles, having the formula-
  • X is an anion which serves to provide electronic neutrality to the bis-quaternary cis tetracycle.
  • electroactive neutrality refers to "a sufficient amount of an anionic species which satisfies the molecular charge balance requirements" and that a mixture of mono-, di-, tri-. etc. electronic species may be use herein.
  • X preferably has unit negative charge, for example, halogen, tosylate, methylsulfate, ethylsulfate.
  • X may have more than one negative charge, for example, sulfate, in which case the formulator requires only half the amount necessary when using a unit negative-charged anion.
  • Preferred X is chloride, bromide, iodide, sulfate, ethyl sulfate, methyl sulfate, tosylate, mesylate, triflate, and mixtures thereof.
  • Step (a) comprises the reductive cleavage via catalytic hydrogenation as outlined in the following scheme'
  • Step (a) is conducted in the presence of a catalyst, preferably a supported catalyst.
  • a catalyst preferably a supported catalyst.
  • catalysts include platinum on carbon, palladium on carbon (Pd/C), palladium hydroxide on carbon (Pd(OH) 2 /C), rhodium on carbon (Rh/C), Raney nickel, and mixtures thereof.
  • a preferred catalyst is Pd(0H) /C.
  • the supported catalysts may comprise from about 1% to about 50% by weight of transition metal, however, the pure metal, i.e. palladium, can be used without the need for a "support", i.e., carbon.
  • catalytic amount of catalyst is sufficient to provide the reduction of step (a).
  • the term catalytic amount is defined as "from about 1 ppm of a 5% by weight transition metal catalyst".
  • the formulator, due to poisoning of the catalyst surface by reaction products may use more than a catalytic amount of a catalyst.
  • the amount of catalyst used in step (a) of the present invention is preferably from about 10 ppm of a catalyst which contains from about 5% to 50% by weight, of a transition metal, more preferably from about 100 ppm, yet more preferably from about 0.1% by weight, of a transition metal supported catalyst
  • a reaction solution which comprises 0.1% by weight, of a transition metal supported catalyst, said catalyst comprising, for example, 10% by weight of palladium on carbon, has 0.01% transition metal or 100 ppm transition metal present.
  • step (a) of the present invention need only be enough to sufficiently saturate the catalyst surface, preferably the hydrogen pressure is from 200 psi, more preferably from 400 psi, most preferably from 800 psi to about 2000 psi, more preferably to 1000 psi.
  • Step (a) of the present process can be conducted at a temperature of from 20° C, preferably from about 40° C, more preferably from about 60° C to about 100° C, preferably to about 90° C, more preferably to about 80° C, most preferably to about 65° C.
  • the pH under which Step (a) must be conducted is at least 8, preferably at least 10, more preferably at least about 11.
  • the base which is used to adjust the pH is in the form of an aqueous solution.
  • Preferred bases are selected from the group consisting of potassium carbonate, sodium carbonate, sodium hydroxide, potassium hydroxide, and mixtures thereof. As a non-limiting example, it is satisfactory to use a sufficient amount of 1 M (molar) aqueous base to adjust the pH to the required level.
  • a convenient and preferred base is potassium carbonate.
  • Step (a) can be conducted in the presence of a solvent other than water, or m the absence of water.
  • a mixture of a suitable solvent and water is a suitable means for conducting the hydrogenation process of the present invention.
  • water is absent, sufficient base must be present to stabilize the transition state of the reactants and products during hydrogenation.
  • solvents include methanol, ethanol, n- propanol, isopropanol, N.N-dimethyl formamide, n-butanol. iso-butanol, tert-butanol, and mixtures thereof; preferred solvents are selected from the group consisting of ethanol, n- propanol, N,N-d ⁇ methyl formamide, and mixtures thereof.
  • the ratio of said volume of an aqueous base, to said solvent is from about 1 : 10 to about 1 : 1, preferably the ratio of the volume of aqueous base to solvent is 1 :4. It is desirable, but not a requirement, that the aqueous base and solvent form a two phase system.
  • Step (b) is an isolation step.
  • this step involves filtration of the reaction solution to remove the catalyst.
  • this step may comprise a neutralization step, however, the product can be isolated or removed from the reaction matrix in any manner which the formulator desires.
  • the reaction solution containing the cross- bridged hgand is filtered to remove the catalyst to form a crude filtrate.
  • This crude filtrate can be neutralized or the tetraaza macrocychc hgand can be isolated by extraction or crystallization directly from the preferably aqueous solution.
  • Steps (a) and (b) and any optional extensions thereto may be suitably adapted for either batch processes or continuous processes, for example, continuous flow processes.
  • the process of the present invention may comp ⁇ se other optional steps as deemed necessary and/or desirable by the formulator. These optional steps may include but are not limited to, pre-saturation of the catalyst with hydrogen, drawing a vacuum on the system, and recovery of the catalyst and solvents.
  • the ligands formed by the process of the present invention are converted into manganese containing transition metal catalysts in a subsequent, however optional, process step
  • the bleach catalysts comprise a central manganese atom and a cross-branched hgand formed by the process of the present invention.
  • the final bleach catalyst may comprise one or more other compatible ligands inter aha chlorine atom.
  • the preferred catalysts are suitable as bleaching agents.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catalysts (AREA)

Abstract

The present invention relates to a process for preparing a cross-bridged tetraaza macrocyclic ligand having formula (I) wherein each R is independently C1-C8 linear or branched alkyl, -(CH2)xCO2M, and mixtures thereof; provided both of the R units are not methyl; M is hydrogen or a salt forming cation; x is from 1 to 6; each index n is independently from 0 to 3; by contacting a di-quaternary cis tetracycle precursor with hydrogen in the presence of a palladium catalyst in an aqueous solution having a pH of at least about 10 at a temperature of about 40 °C to about 100 °C.

Description

PROCESS FOR PREPARING CROSS-BRIDGED TETRAAZA MACROCYCLES
FIELD OF THE INVENTION The present invention relates to an improved process for preparing cross-bridged tetraaza macrocycles, said macrocycles suitable as ligands for use m preparing transition metal complexes The present invention provides a process which is well suited for use in industrial and other commercial preparations of the herein described crossed-bπdged macrocycles.
BACKGROUND OF THE INVENTION Tetraaza macrocyclics, for example, cyclam, have been prepared in numerous ways, however, there is a paucity of information relating to the preparation of cross-bridged tetraaza macrocyclics inter aha bis N-substituted tetraaza macrocyclics inter alia 5,12 dialkyl 1,5,8,12- tetraaza-bιcyclo[6.6.2]hexadecanes which have recently found wide applicability as ligands especially in the area of transition metal catalysts inter alia bleach catalysts.
WO 98/39335 Al "Improved Methods of Making Cross-Bridged Macropoly-cycles" discloses a rational procedure for preparing cross bridged macropolycychc ligands which is amenable to high yields necessary for industrial scale-up. However, the reductive ring cleavage step which results in bicyclo bridged-ring formation utilizes a borohydπde reducing agent. This type of reducing agent can place constraints on the formulator. For example, the need to break up the amine/borohydπde complex duπng work-up and the proper recovery and disposal of boron waste products adds cost to the process. Also, if excess borohydπde is needed, this requires neutralization which involves the use of acid and the evolution of large quantities of hydrogen gas.
Therefore, a need exists for a highly quantitative, preferably catalytic, process for preparing cross-bridged macropolycychc ligands which is adaptable to either continuous flow processes or batch preparations.
SUMMARY OF THE INVENTION The present invention meets the aforementioned needs m that it has been surprisingly discovered that select bis N-substituted tetraaza macrocyclics can be converted to cross-bridged macropolycychc ligands via catalytic hydrogenation. A first aspect of the present invention relates to a process for preparing a tetraaza macrocychc hgand having the formula:
Figure imgf000004_0001
wherein each R is independently Cj-Cg linear or branched alkyl, -(CH2)xC02M, and mixtures thereof, preferably both of the R units are not methyl; M is hydrogen or a salt forming cation; x is from 1 to 6; each index n is independently from 0 to 3; said process comprising the steps of a) hydrogenat g a tetraaza macrocychc hgand precursor having the formula:
Figure imgf000004_0002
wherein X is an anion which provides charge neutrality, with from about 1 ppm of a transition metal hydrogenation catalyst at a pH of at least 8 to form a tetraaza macrocychc hgand; and b) optionally isolating said hgand.
These and other objects, features, and advantages will become apparent to those of ordinary skill in the art from a reading of the following detailed description and the appended claims. All percentages, ratios and proportions herein are by weight, unless otherwise specified. All temperatures are in degrees Celsius (° C) unless otherwise specified. All documents cited are in relevant part, incorporated herein by reference.
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to the catalytic hydrogenation of tetraaza macrocycles having the formula:
Figure imgf000005_0001
wherein the covalent bond between the N-substituted quaternary ring nitrogen and the bridging carbon is broken and a cross-bridged macrocychc hgand having the formula:
Figure imgf000005_0002
is the resulting product.
In the above formula each R is independently Cj-C8 linear or branched alkyl, - (CH2)sC02M, and mixtures thereof, preferably both of the R units are not methyl; more preferably one R unit is methyl and the other R unit is selected from the group consisting of ethyl, propyl, butyl, pentyl, hexyl. and mixtures thereof; of the methyl/alkyl R unit mixtures preferably one R is methyl and the other R is ethyl or propyl. A most preferred hgand consists of a unit wherein one R unit is methyl and the other R unit is ethyl. A preferred gand is a macrocychc ring wherein each R unit is ethyl. M is hydrogen or a salt forming cation, non-limiting examples of which are sodium, potassium, calcium, ammonium. When R is -(CH2)xC02M the index x has the value from 1 to about 6. preferably x is 1. The index n defines the size of the macrocychc ring. The index n has the value of from 0 to about 3. A preferred macrocychc ring has one opposite set of n indices equal to 1 and the other set of n indices equal to 0 as in the general formula:
Figure imgf000006_0001
wherein R is the same as defined herein above.
Preferred ligands according to the present invention comprise R unit pairs which are selected from the group consisting of methyl and ethyl, di ethyl, methyl and propyl, ethyl and propyl, methyl and butyl, ethyl and butyl, and mixtures thereof.
The starting materials for the process of the present invention are tetraaza macrocychc hgand precursors, or alternatively, bis-quaternary as tetracycles, having the formula-
Figure imgf000006_0002
wherein R and n are the same as defined herein above. X is an anion which serves to provide electronic neutrality to the bis-quaternary cis tetracycle. Those of ordinary skill in the art recognize that the term "electronic neutrality" refers to "a sufficient amount of an anionic species which satisfies the molecular charge balance requirements" and that a mixture of mono-, di-, tri-. etc. electronic species may be use herein. X preferably has unit negative charge, for example, halogen, tosylate, methylsulfate, ethylsulfate. However, X may have more than one negative charge, for example, sulfate, in which case the formulator requires only half the amount necessary when using a unit negative-charged anion. Preferred X is chloride, bromide, iodide, sulfate, ethyl sulfate, methyl sulfate, tosylate, mesylate, triflate, and mixtures thereof.
STEP (a) Hydrogenation - Reductive Cleavage
Step (a) comprises the reductive cleavage via catalytic hydrogenation as outlined in the following scheme'
Figure imgf000007_0001
wherein the -tetracycle bis quaternary salt is converted to the cross-bridged tetraaza macrocycle. Step (a) is conducted in the presence of a catalyst, preferably a supported catalyst. Non- hmiting examples of catalysts include platinum on carbon, palladium on carbon (Pd/C), palladium hydroxide on carbon (Pd(OH)2/C), rhodium on carbon (Rh/C), Raney nickel, and mixtures thereof. A preferred catalyst is Pd(0H) /C. The supported catalysts may comprise from about 1% to about 50% by weight of transition metal, however, the pure metal, i.e. palladium, can be used without the need for a "support", i.e., carbon. A "catalytic amount" of catalyst is sufficient to provide the reduction of step (a). For the purposes of the present invention the term catalytic amount is defined as "from about 1 ppm of a 5% by weight transition metal catalyst". However, the formulator, due to poisoning of the catalyst surface by reaction products may use more than a catalytic amount of a catalyst. The amount of catalyst used in step (a) of the present invention is preferably from about 10 ppm of a catalyst which contains from about 5% to 50% by weight, of a transition metal, more preferably from about 100 ppm, yet more preferably from about 0.1% by weight, of a transition metal supported catalyst A reaction solution which comprises 0.1% by weight, of a transition metal supported catalyst, said catalyst comprising, for example, 10% by weight of palladium on carbon, has 0.01% transition metal or 100 ppm transition metal present.
The amount of hydrogen gas present in step (a) of the present invention need only be enough to sufficiently saturate the catalyst surface, preferably the hydrogen pressure is from 200 psi, more preferably from 400 psi, most preferably from 800 psi to about 2000 psi, more preferably to 1000 psi. Step (a) of the present process can be conducted at a temperature of from 20° C, preferably from about 40° C, more preferably from about 60° C to about 100° C, preferably to about 90° C, more preferably to about 80° C, most preferably to about 65° C. The pH under which Step (a) must be conducted is at least 8, preferably at least 10, more preferably at least about 11. Preferably the base which is used to adjust the pH is in the form of an aqueous solution. Preferred bases are selected from the group consisting of potassium carbonate, sodium carbonate, sodium hydroxide, potassium hydroxide, and mixtures thereof. As a non-limiting example, it is satisfactory to use a sufficient amount of 1 M (molar) aqueous base to adjust the pH to the required level. A convenient and preferred base is potassium carbonate.
As a suitable alternative, Step (a) can be conducted in the presence of a solvent other than water, or m the absence of water. A mixture of a suitable solvent and water is a suitable means for conducting the hydrogenation process of the present invention. In the case where water is absent, sufficient base must be present to stabilize the transition state of the reactants and products during hydrogenation. Non-limiting examples of solvents include methanol, ethanol, n- propanol, isopropanol, N.N-dimethyl formamide, n-butanol. iso-butanol, tert-butanol, and mixtures thereof; preferred solvents are selected from the group consisting of ethanol, n- propanol, N,N-dιmethyl formamide, and mixtures thereof. When a solvent is present and the base is in the form of an aqueous solution, the ratio of said volume of an aqueous base, to said solvent is from about 1 : 10 to about 1 : 1, preferably the ratio of the volume of aqueous base to solvent is 1 :4. It is desirable, but not a requirement, that the aqueous base and solvent form a two phase system.
The process of the present invention comprises an optional, although preferred, Step (b) which is an isolation step. Typically this step involves filtration of the reaction solution to remove the catalyst. In addition, this step may comprise a neutralization step, however, the product can be isolated or removed from the reaction matrix in any manner which the formulator desires.
When filtration of the catalyst is a desired step, the reaction solution containing the cross- bridged hgand is filtered to remove the catalyst to form a crude filtrate. This crude filtrate can be neutralized or the tetraaza macrocychc hgand can be isolated by extraction or crystallization directly from the preferably aqueous solution.
Steps (a) and (b) and any optional extensions thereto, for example, a crystallization step, a solvent drying step, a purging step, may be suitably adapted for either batch processes or continuous processes, for example, continuous flow processes. As mentioned herein, the process of the present invention may compπse other optional steps as deemed necessary and/or desirable by the formulator. These optional steps may include but are not limited to, pre-saturation of the catalyst with hydrogen, drawing a vacuum on the system, and recovery of the catalyst and solvents. Preferably the ligands formed by the process of the present invention are converted into manganese containing transition metal catalysts in a subsequent, however optional, process step The bleach catalysts comprise a central manganese atom and a cross-branched hgand formed by the process of the present invention. The final bleach catalyst may comprise one or more other compatible ligands inter aha chlorine atom. The preferred catalysts are suitable as bleaching agents.
The following is a non-hmitmg example of the process of the present invention.
Preparation of 5,12-diethyl-l ,5,8,12-tetraaza-bicvclo [6.6.21 hexadecane To a thick walled, glass autoclave sleeve is added the bis-quaternary as tetracycle having the formula:
Figure imgf000009_0001
(3.0 g, 6.8 mmol) and a 1M aqueous solution of K2C03 (30 mL). The solution is agitated to dissolve the substrate then 20% Pd(OH)2/carbon (0.7 g, 1.0 mmol) is added. The glass sleeve is placed into a rocking autoclave and hydrogenated at 65° C with 1900 psig hydrogen for 4 hours. The reaction is cooled and the solution filtered through glass fiber filter paper to remove the catalyst and the filtrate is reduced to a white solid under vacuum The white solid is suspended in refluxmg ethanol and the un-dissolved inorganic salts are collected by filtration. After concentrating the filtrate under vacuum, the resulting oily residue is dissolved in aqueous 4M KOH (4 mL) and extracted three times with 25 mL portions of toluene. The toluene extracts are combined and concentrated in vacuo to afford 5,12-dιethyl-l,5,8,12-tetraaza- bιcyclo[6.6.2]hexadecane (1.56 g) in 81% yield as a clear oil.
The following is an example of an optional, but preferred step of the process of the present invention which is conversion to a manganese transition metal bleach catalyst. Preparation of dichloro 5,12-diethyl-l,5,8,12-tetraaza- bicvclo [6.6.21 hexadecane manganese To a 100 mL reaction flask is charged anhydrous acetonitπle (50 mL) and 5,12-dιethyl- l,5,8,12-tetraaza-bιcyclo[6.6.2]hexadecane (1 4 g, 5 mmol). The resulting suspension is degassed under vacuum with subsequent re-filhng with argon. This process is repeated six times Manganese(II) chloride (0.590 g, 4.7 mmol) is added and the reaction is refluxed for 3 hours The resulting solution is filtered through glass-fiber filter paper. The resulting filtrate is concentrated under reduced pressure at 45° C to afford a solid. The solid is suspended in toluene (50 mL) and the resulting dark supernatant is discarded. Treatment with toluene is repeated five times. The resulting solid is dried under vacuum to yield dichloro 5,12-dιethyl-l,5,8,12-tetraaza- bιcyclo[6.6.2]hexadecane manganese (1.48 g, 73% yield).

Claims

WHAT IS CLAIMED IS :
A process for preparing a tetraaza macrocychc hgand having the formula:
Figure imgf000011_0001
wherein each R is independently C C8 linear or branched alkyl, -(CH2) C02M, and mixtures thereof, provided both of the R units are not methyl; M is hydrogen or a salt forming cation; x is from 1 to 6; each index n is independently from 0 to 3; said process comprising the steps of: a) hydrogenating a tetraaza macrocychc hgand precursor having the formula:
Figure imgf000011_0002
wherein X ' is an anion which provides charge neutrality, with from 1 ppm of a transition metal hydrogenation catalyst at a pH of at least 8 to form a tetraaza macrocychc hgand; and b) optionally isolating said hgand.
2. A process according to Claim 1 wherein said transition metal hydrogenation catalyst is selected from the group consisting of platinum, palladium, palladium hydroxide, rhodium, Raney nickel, and mixtures thereof.
A process according to either of Claims 1 or 2 wherein step (a) is conducted at a temperature of from 40° C to 100° C, at a pH of at least 10, and in the presence of a solvent, said solvent selected from the group consisting of water, N,N-dιmethyl formamide, methanol. ethanol, isopropanol, n-butanol, iso-butanol, tert-butanol, and mixtures thereof.
4. A process according any of Claims 1-3 wherein said precursor has the formula:
Figure imgf000012_0001
wherein R and X are the same as defined herein above.
5. A process according to any of Claims 1-4 wherein each R is ethyl.
6. A process according to any of Claims 1-5 wherein one R is methyl and one R is ethyl.
A process for preparing a tetraaza macrocychc hgand having the formula:
Figure imgf000012_0002
wherein one R unit is methyl and the other R unit is selected from the group consisting of ethyl, propyl, butyl, pentyl, hexyl, and mixtures thereof; said process comprising the steps of: a) hydrogenating a tetraaza macrocychc hgand precursor having the formula:
Figure imgf000013_0001
wherein X " is an anion which provides charge neutrality, with from 1 ppm of a palladium hydrogenation catalyst at a pH of at least 10 to form a tetraaza macrocychc hgand; and b) optionally isolating said hgand.
A process for preparing a tetraaza macrocychc hgand having the formula:
Figure imgf000013_0002
wherein each R is independently C C8 linear or branched alkyl, -(CH2) C02M, and mixtures thereof, provided both of the R units are not methyl; M is hydrogen or a salt forming cation; x is from 1 to 6; each index n is independently from 0 to 3; said process compπsmg the steps of: a) hydrogenating a tetraaza macrocychc hgand precursor having the formula:
Figure imgf000013_0003
wherein X " is an anion which provides charge neutrality, with from 1 ppm of a palladium hydrogenation catalyst, said palladium catalyst selected from the group consisting of supported palladιum(O). palladium hydroxide, and mixtures thereof; at a pH of at least 8; in the presence of a solvent, said solvent selected from the group consisting of water, methanol, ethanol, N,N-dιmethyl formamide, n-butanol, iso-butanol, tert-butanol, and mixture thereof, at a temperature of from 0° C to 100° C; to form a tetraaza macrocychc hgand; and b) removing the catalyst by filtration to form a crude filtrate: c) optionally isolating said hgand by crystallizing, extracting, distilling, or other suitable means.
A process according to Claim 8 wherein said process further comprises the step of treating said hgand with manganese to form a cross-bridged tetraaza macrocychc transition metal catalyst.
A process for preparing a tetraaza macrocychc hgand having the formula:
Figure imgf000014_0001
wherein R units are R unit pairs selected from the group consisting of methyl and ethyl, diethyl, methyl and propyl, ethyl and propyl, methyl and butyl, ethyl and butyl, and mixtures thereof; M is hydrogen or a salt forming cation; x is from 1 to 6; each index n is independently from 0 to 3; said process composing the steps of: a) hydrogenatmg a tetraaza macrocychc hgand precursor having the formula:
Figure imgf000014_0002
wherein X " is an anion which provides charge neutrality, with from 1 ppm of a transition metal hydrogenation catalyst at a pH of at least 8 to form a tetraaza macrocychc hgand; and b) optionally isolating said hgand.
11. A transition metal catalyst comprising: a) a crossed-bπdged hgand having the formula:
Figure imgf000015_0001
wherein each R is independently C C8 linear or branched alkyl, -(CH2)χC02M, and mixtures thereof, provided both of the R units are not methyl or butyl; M is hydrogen or a salt forming cation; x is from 1 to 6; each index n is independently from O to 3; b) manganese; and c) optionally one or more compatible ligands.
12. A compound according to Claim 11 having the formula:
Figure imgf000015_0002
PCT/US1999/027316 1998-11-30 1999-11-18 Process for preparing cross-bridged tetraaza macrocycles Ceased WO2000032601A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002348893A CA2348893A1 (en) 1998-11-30 1999-11-18 Process for preparing cross-bridged tetraaza macrocycles
JP2000585243A JP2002531457A (en) 1998-11-30 1999-11-18 Method for producing cross-linked tetraaza macrocycles
AU20261/00A AU2026100A (en) 1998-11-30 1999-11-18 Process for preparing cross-bridged tetraaza macrocycles
EP99963923A EP1135392A2 (en) 1998-11-30 1999-11-18 Process for preparing cross-bridged tetraaza macrocycles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11030998P 1998-11-30 1998-11-30
US60/110,309 1998-11-30

Publications (2)

Publication Number Publication Date
WO2000032601A2 true WO2000032601A2 (en) 2000-06-08
WO2000032601A3 WO2000032601A3 (en) 2000-10-05

Family

ID=22332328

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/027316 Ceased WO2000032601A2 (en) 1998-11-30 1999-11-18 Process for preparing cross-bridged tetraaza macrocycles

Country Status (5)

Country Link
EP (1) EP1135392A2 (en)
JP (1) JP2002531457A (en)
AU (1) AU2026100A (en)
CA (1) CA2348893A1 (en)
WO (1) WO2000032601A2 (en)

Cited By (264)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002026267A3 (en) * 2000-09-25 2003-04-03 Procter & Gamble Manganes complexes for magnetic resonance imaging
FR2830253A1 (en) * 2001-09-28 2003-04-04 Air Liquide NEW PROCESS FOR THE PREPARATION OF C-FUNCTIONALIZED NITROGEN MACROCYCLES AND NEW INTERMEDIATES OBTAINED
FR2856063A1 (en) * 2003-06-13 2004-12-17 Air Liquide 1,4,7,10-Tetraaza-cyclododecane production, e.g. for use in production of medical imaging contrast agents, from triethylene tetramine or ethylene diamine via new or known tetracyclic bis-aminal intermediates
US7169744B2 (en) 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
EP1754781A1 (en) 2005-08-19 2007-02-21 The Procter and Gamble Company A solid laundry detergent composition comprising anionic detersive surfactant and a calcium-augmented technology
WO2007044993A2 (en) 2005-10-12 2007-04-19 Genencor International, Inc. Use and production of storage-stable neutral metalloprotease
WO2007049188A1 (en) 2005-10-24 2007-05-03 The Procter & Gamble Company Fabric care compositions and systems comprising organosilicone microemulsions and methods employing same
WO2007100501A2 (en) 2006-02-28 2007-09-07 Appleton Papers Inc. Benefit agent containing delivery particle
WO2007144856A2 (en) 2006-06-16 2007-12-21 The Procter & Gamble Company Cleaning and / or treatment compositions comprising mutant alpha-amylases
WO2008066773A2 (en) 2006-11-22 2008-06-05 The Procter & Gamble Company Benefit agent- containing delivery particle
US7425527B2 (en) 2004-06-04 2008-09-16 The Procter & Gamble Company Organic activator
WO2008152543A1 (en) 2007-06-11 2008-12-18 The Procter & Gamble Company Benefit agent containing delivery particle
US7504371B2 (en) 2005-06-17 2009-03-17 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
EP2048589A2 (en) 2007-10-03 2009-04-15 The Procter and Gamble Company Modeling systems for consumer goods
EP2071017A1 (en) 2007-12-04 2009-06-17 The Procter and Gamble Company Detergent composition
US7557076B2 (en) 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
EP2083065A1 (en) 2008-01-22 2009-07-29 The Procter and Gamble Company Colour-Care Composition
WO2009149144A2 (en) 2008-06-06 2009-12-10 Danisco Us Inc. Compositions and methods comprising variant microbial proteases
EP2135932A1 (en) 2008-06-20 2009-12-23 The Procter and Gamble Company Laundry composition
EP2135933A1 (en) 2008-06-20 2009-12-23 The Procter and Gamble Company Laundry composition
WO2010014172A2 (en) 2008-07-30 2010-02-04 Appleton Papers Inc. Delivery particle
US7671005B2 (en) 2004-02-13 2010-03-02 The Procter & Gamble Company Active containing delivery particle
EP2163608A1 (en) 2008-09-12 2010-03-17 The Procter & Gamble Company Laundry particle made by extrusion comprising a hueing dye and fatty acid soap
EP2166077A1 (en) 2008-09-12 2010-03-24 The Procter and Gamble Company Particles comprising a hueing dye
EP2166078A1 (en) 2008-09-12 2010-03-24 The Procter & Gamble Company Laundry particle made by extrusion comprising a hueing dye
US7686892B2 (en) 2004-11-19 2010-03-30 The Procter & Gamble Company Whiteness perception compositions
EP2177259A2 (en) 2005-09-01 2010-04-21 The Procter and Gamble Company Method of processing materials
US7790666B2 (en) 2006-01-23 2010-09-07 The Procter & Gamble Company Detergent compositions
WO2010114753A1 (en) 2009-04-02 2010-10-07 The Procter & Gamble Company Composition comprising delivery particles
EP2248883A1 (en) 2006-01-23 2010-11-10 The Procter and Gamble Company Enzyme and fabric hueing agent containing compositions
WO2011002825A1 (en) 2009-06-30 2011-01-06 The Procter & Gamble Company Rinse added aminosilicone containing compositions and methods of using same
WO2011002864A1 (en) 2009-06-30 2011-01-06 The Procter & Gamble Company Aminosilicone containing detergent compositions and methods of using same
WO2011005904A1 (en) 2009-07-09 2011-01-13 The Procter & Gamble Company Detergent composition
WO2011005943A1 (en) 2009-07-10 2011-01-13 The Procter & Gamble Company Compositions containing benefit agent delivery particles
WO2011005932A1 (en) 2009-07-10 2011-01-13 The Procter & Gamble Company Compositions containing benefit agent delivery particles
WO2011016958A2 (en) 2009-07-27 2011-02-10 The Procter & Gamble Company Detergent composition
WO2011026154A2 (en) 2010-10-29 2011-03-03 The Procter & Gamble Company Cleaning and/or treatment compositions
US7901772B2 (en) 2005-09-27 2011-03-08 The Procter & Gamble Company Microcapsule and method of producing same
EP2292743A2 (en) 2003-12-03 2011-03-09 Genencor International, Inc. Perhydrolase
US7910538B2 (en) 2008-06-04 2011-03-22 The Procter & Gamble Company Detergent composition
EP2301517A1 (en) 2006-08-01 2011-03-30 The Procter & Gamble Company Benefit agent containing delivery particle
WO2011056934A1 (en) 2009-11-06 2011-05-12 The Procter & Gamble Company High efficiency capsules comprising benefit agent
WO2011072117A1 (en) 2009-12-09 2011-06-16 The Procter & Gamble Company Fabric and home care products
WO2011072099A2 (en) 2009-12-09 2011-06-16 Danisco Us Inc. Compositions and methods comprising protease variants
WO2011075551A1 (en) 2009-12-18 2011-06-23 The Procter & Gamble Company Perfumes and perfume encapsulates
WO2011075556A1 (en) 2009-12-18 2011-06-23 The Procter & Gamble Company Composition comprising encapsulates, and process for making them
WO2011084599A1 (en) 2009-12-21 2011-07-14 Danisco Us Inc. Detergent compositions containing bacillus subtilis lipase and methods of use thereof
WO2011084417A1 (en) 2009-12-21 2011-07-14 Danisco Us Inc. Detergent compositions containing geobacillus stearothermophilus lipase and methods of use thereof
WO2011084412A1 (en) 2009-12-21 2011-07-14 Danisco Us Inc. Detergent compositions containing thermobifida fusca lipase and methods of use thereof
WO2011090957A2 (en) 2010-01-21 2011-07-28 The Procter & Gamble Company Process of preparing a particle
WO2011100420A1 (en) 2010-02-12 2011-08-18 The Procter & Gamble Company Benefit compositions comprising crosslinked polyglycerol esters
WO2011100411A1 (en) 2010-02-12 2011-08-18 The Procter & Gamble Company Benefit compositions comprising polyglycerol esters
WO2011100405A1 (en) 2010-02-12 2011-08-18 The Procter & Gamble Company Benefit compositions comprising crosslinked polyglycerol esters
WO2011100500A1 (en) 2010-02-12 2011-08-18 The Procter & Gamble Company Benefit compositions comprising polyglycerol esters
WO2011109322A1 (en) 2010-03-04 2011-09-09 The Procter & Gamble Company Detergent composition
US8021436B2 (en) 2007-09-27 2011-09-20 The Procter & Gamble Company Cleaning and/or treatment compositions comprising a xyloglucan conjugate
WO2011130222A2 (en) 2010-04-15 2011-10-20 Danisco Us Inc. Compositions and methods comprising variant proteases
WO2011133306A1 (en) 2010-04-19 2011-10-27 The Procter & Gamble Company Detergent composition
US8048412B2 (en) 2008-02-11 2011-11-01 Danisco Us Inc. Enzyme with microbial lysis activity from Trichoderma reesei
WO2011146602A2 (en) 2010-05-18 2011-11-24 Milliken & Company Optical brighteners and compositions comprising the same
WO2011146604A2 (en) 2010-05-18 2011-11-24 Milliken & Company Optical brighteners and compositions comprising the same
WO2011150138A1 (en) 2010-05-26 2011-12-01 The Procter & Gamble Company Encapsulates
WO2011149871A1 (en) 2010-05-28 2011-12-01 Milliken & Company Colored speckles having delayed release properties
WO2011150157A2 (en) 2010-05-28 2011-12-01 Danisco Us Inc. Detergent compositions containing streptomyces griseus lipase and methods of use thereof
WO2011163325A1 (en) 2010-06-22 2011-12-29 The Procter & Gamble Company Perfume systems
WO2011163337A1 (en) 2010-06-22 2011-12-29 The Procter & Gamble Company Perfume systems
WO2012003192A1 (en) 2010-06-30 2012-01-05 The Procter & Gamble Company Rinse added aminosilicone containing compositions and methods of using same
WO2012012494A1 (en) 2010-07-20 2012-01-26 The Procter & Gamble Company Particles with a plurality of coatings
WO2012012475A1 (en) 2010-07-20 2012-01-26 The Procter & Gamble Company Delivery particles with a plurality of cores
WO2012040171A1 (en) 2010-09-20 2012-03-29 The Procter & Gamble Company Non-fluoropolymer surface protection composition
WO2012040131A2 (en) 2010-09-20 2012-03-29 The Procter & Gamble Company Fabric care formulations and methods
WO2012040130A1 (en) 2010-09-20 2012-03-29 The Procter & Gamble Company Non-fluoropolymer surface protection composition
WO2012057781A1 (en) 2010-10-29 2012-05-03 The Procter & Gamble Company Cleaning and/or treatment compositions comprising a fungal serine protease
US8183024B2 (en) 2008-11-11 2012-05-22 Danisco Us Inc. Compositions and methods comprising a subtilisin variant
EP2468239A1 (en) 2010-12-21 2012-06-27 Procter & Gamble International Operations SA Encapsulates
US8247364B2 (en) 2007-01-19 2012-08-21 The Procter & Gamble Company Whitening agents for cellulosic substrates
WO2012116014A1 (en) 2011-02-25 2012-08-30 Milliken & Company Capsules and compositions comprising the same
US8278230B2 (en) 2007-06-05 2012-10-02 The Procter & Gamble Company Perfume systems
WO2012142087A1 (en) 2011-04-12 2012-10-18 The Procter & Gamble Company Metal bleach catalysts
WO2012149317A1 (en) 2011-04-29 2012-11-01 Danisco Us Inc. Detergent compositions containing bacillus agaradhaerens mannanase and methods of use thereof
WO2012149325A1 (en) 2011-04-29 2012-11-01 Danisco Us Inc. Detergent compositions containing geobacillus tepidamans mannanase and methods of use thereof
WO2012149333A1 (en) 2011-04-29 2012-11-01 Danisco Us Inc. Detergent compositions containing bacillus sp. mannanase and methods of use thereof
WO2012151534A1 (en) 2011-05-05 2012-11-08 Danisco Us Inc. Compositions and methods comprising serine protease variants
WO2012151480A2 (en) 2011-05-05 2012-11-08 The Procter & Gamble Company Compositions and methods comprising serine protease variants
EP2537918A1 (en) 2011-06-20 2012-12-26 The Procter & Gamble Company Consumer products with lipase comprising coated particles
WO2012177357A1 (en) 2011-06-23 2012-12-27 The Procter & Gamble Company Perfume systems
WO2013006871A2 (en) 2012-02-13 2013-01-10 Milliken & Company Laundry care compositions containing dyes
WO2013022949A1 (en) 2011-08-10 2013-02-14 The Procter & Gamble Company Encapsulates
WO2013033318A1 (en) 2011-08-31 2013-03-07 Danisco Us Inc. Compositions and methods comprising a lipolytic enzyme variant
WO2013040114A1 (en) 2011-09-13 2013-03-21 The Procter & Gamble Company Encapsulates
EP2581438A1 (en) 2011-10-12 2013-04-17 The Procter and Gamble Company Detergent composition
US8431520B2 (en) 2008-12-01 2013-04-30 The Procter & Gamble Company Perfume systems
EP2589651A2 (en) 2008-11-11 2013-05-08 Danisco US Inc. Compositions and methods comprising serine protease variants
US8450259B2 (en) 2007-02-15 2013-05-28 The Procter & Gamble Company Benefit agent delivery compositions
WO2013096653A1 (en) 2011-12-22 2013-06-27 Danisco Us Inc. Compositions and methods comprising a lipolytic enzyme variant
WO2013109798A2 (en) 2012-01-18 2013-07-25 The Procter & Gamble Company Perfume systems
EP2623586A2 (en) 2012-02-03 2013-08-07 The Procter & Gamble Company Compositions and methods for surface treatment with lipases
WO2013113622A1 (en) 2012-02-03 2013-08-08 Novozymes A/S Lipase variants and polynucleotides encoding same
US8512418B2 (en) 2008-01-04 2013-08-20 The Procter & Gamble Company Enzyme and fabric hueing agent containing compositions
US8530219B2 (en) 2008-11-11 2013-09-10 Danisco Us Inc. Compositions and methods comprising a subtilisin variant
US8535927B1 (en) 2003-11-19 2013-09-17 Danisco Us Inc. Micrococcineae serine protease polypeptides and compositions thereof
WO2013142486A1 (en) 2012-03-19 2013-09-26 The Procter & Gamble Company Laundry care compositions containing dyes
WO2013148639A1 (en) 2012-03-26 2013-10-03 The Procter & Gamble Company Cleaning compositions comprising ph-switchable amine surfactants
WO2013149858A1 (en) 2012-04-02 2013-10-10 Novozymes A/S Lipase variants and polynucleotides encoding same
US8569034B2 (en) 2007-11-01 2013-10-29 Danisco Us Inc. Thermolysin variants and detergent compositions therewith
US8580720B2 (en) 2008-01-04 2013-11-12 The Procter & Gamble Company Laundry detergent composition comprising a glycosyl hydrolase and a benefit agent containing delivery particle
WO2013171241A1 (en) 2012-05-16 2013-11-21 Novozymes A/S Compositions comprising lipase and methods of use thereof
EP2674475A1 (en) 2012-06-11 2013-12-18 The Procter & Gamble Company Detergent composition
EP2712915A1 (en) 2012-10-01 2014-04-02 The Procter and Gamble Company Methods of treating a surface and compositions for use therein
WO2014059360A1 (en) 2012-10-12 2014-04-17 Danisco Us Inc. Compositions and methods comprising a lipolytic enzyme variant
WO2014066309A1 (en) 2012-10-24 2014-05-01 The Procter & Gamble Company Anti foam compositions comprising partly phenyl bearing polyorganosilicons
WO2014066308A1 (en) 2012-10-24 2014-05-01 The Procter & Gamble Company Anti foam compositions comprising aryl bearing polyorganosilicons
WO2014071410A1 (en) 2012-11-05 2014-05-08 Danisco Us Inc. Compositions and methods comprising thermolysin protease variants
US8753861B2 (en) 2008-11-11 2014-06-17 Danisco Us Inc. Protease comprising one or more combinable mutations
US8754028B2 (en) 2008-12-16 2014-06-17 The Procter & Gamble Company Perfume systems
WO2014100018A1 (en) 2012-12-19 2014-06-26 Danisco Us Inc. Novel mannanase, compositions and methods of use thereof
WO2014138141A1 (en) 2013-03-05 2014-09-12 The Procter & Gamble Company Mixed sugar compositions
WO2014147127A1 (en) 2013-03-21 2014-09-25 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
WO2014184164A1 (en) 2013-05-14 2014-11-20 Novozymes A/S Detergent compositions
EP2806018A1 (en) 2013-05-20 2014-11-26 The Procter & Gamble Company Encapsulates
WO2014189906A2 (en) 2013-05-20 2014-11-27 The Procter & Gamble Company Encapsulates
EP2808372A1 (en) 2013-05-28 2014-12-03 The Procter and Gamble Company Surface treatment compositions comprising photochromic dyes
WO2014194054A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194034A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194117A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194032A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2015004102A1 (en) 2013-07-09 2015-01-15 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
WO2015038792A1 (en) 2013-09-12 2015-03-19 Danisco Us Inc. Compositions and methods comprising lg12-clade protease variants
WO2015042086A1 (en) 2013-09-18 2015-03-26 The Procter & Gamble Company Laundry care composition comprising carboxylate dye
WO2015041887A2 (en) 2013-09-18 2015-03-26 Milliken & Company Laundry care composition comprising carboxylate dye
WO2015042209A1 (en) 2013-09-18 2015-03-26 The Procter & Gamble Company Laundry care compositions containing thiophene azo carboxylate dyes
WO2015042087A1 (en) 2013-09-18 2015-03-26 The Procter & Gamble Company Laundry care composition comprising carboxylate dye
WO2015089441A1 (en) 2013-12-13 2015-06-18 Danisco Us Inc. Serine proteases of bacillus species
WO2015089447A1 (en) 2013-12-13 2015-06-18 Danisco Us Inc. Serine proteases of the bacillus gibsonii-clade
WO2015112340A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Method of treating textile fabrics
WO2015112338A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Method of treating textile fabrics
WO2015112339A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Fabric treatment composition
WO2015112341A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Fabric treatment composition
WO2015158237A1 (en) 2014-04-15 2015-10-22 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
WO2015171592A1 (en) 2014-05-06 2015-11-12 Milliken & Company Laundry care compositions
WO2015181119A2 (en) 2014-05-27 2015-12-03 Novozymes A/S Lipase variants and polynucleotides encoding same
US9243215B2 (en) 2008-11-07 2016-01-26 The Procter & Gamble Company Benefit agent containing delivery particle
WO2016049393A1 (en) 2014-09-26 2016-03-31 The Procter & Gamble Company Method of making perfumed goods
WO2016061438A1 (en) 2014-10-17 2016-04-21 Danisco Us Inc. Serine proteases of bacillus species
WO2016069557A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases of bacillus species
WO2016069552A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069548A2 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069544A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069569A2 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016081437A1 (en) 2014-11-17 2016-05-26 The Procter & Gamble Company Benefit agent delivery compositions
WO2016087401A1 (en) 2014-12-05 2016-06-09 Novozymes A/S Lipase variants and polynucleotides encoding same
WO2016130521A1 (en) 2015-02-10 2016-08-18 The Procter & Gamble Company Liquid laundry cleaning composition
EP3067410A2 (en) 2008-02-15 2016-09-14 The Procter and Gamble Company Cleaning compositions
WO2016145428A1 (en) 2015-03-12 2016-09-15 Danisco Us Inc Compositions and methods comprising lg12-clade protease variants
EP3088505A1 (en) 2015-04-29 2016-11-02 The Procter and Gamble Company Method of treating a fabric
EP3088506A1 (en) 2015-04-29 2016-11-02 The Procter and Gamble Company Detergent composition
EP3088504A1 (en) 2015-04-29 2016-11-02 The Procter and Gamble Company Method of treating a fabric
EP3088502A1 (en) 2015-04-29 2016-11-02 The Procter and Gamble Company Method of treating a fabric
EP3088503A1 (en) 2015-04-29 2016-11-02 The Procter and Gamble Company Method of treating a fabric
WO2016178668A1 (en) 2015-05-04 2016-11-10 Milliken & Company Leuco triphenylmethane colorants as bluing agents in laundry care compositions
WO2016184944A1 (en) 2015-05-19 2016-11-24 Novozymes A/S Odor reduction
WO2016202739A1 (en) 2015-06-16 2016-12-22 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
WO2016205008A1 (en) 2015-06-19 2016-12-22 The Procter & Gamble Company Computer-implemeted method of making perfumed goods
WO2016205755A1 (en) 2015-06-17 2016-12-22 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
WO2017065977A1 (en) 2015-10-13 2017-04-20 The Procter & Gamble Company Laundry care compositions comprising whitening agents for cellulosic substrates
WO2017066337A1 (en) 2015-10-13 2017-04-20 Milliken & Company Novel whitening agents for cellulosic substrates
WO2017065979A1 (en) 2015-10-13 2017-04-20 The Procter & Gamble Company Laundry care compositions comprising whitening agents for cellulosic substrates
WO2017066343A1 (en) 2015-10-13 2017-04-20 Milliken & Company Novel whitening agents for cellulosic substrates
WO2017066334A1 (en) 2015-10-13 2017-04-20 Milliken & Company Novel whitening agents for cellulosic substrates
WO2017065978A1 (en) 2015-10-13 2017-04-20 The Procter & Gamble Company Laundry care compositions comprising whitening agents for cellulosic substrates
WO2017079756A1 (en) 2015-11-05 2017-05-11 Danisco Us Inc Paenibacillus and bacillus spp. mannanases
WO2017079751A1 (en) 2015-11-05 2017-05-11 Danisco Us Inc Paenibacillus sp. mannanases
EP3173467A1 (en) 2015-11-26 2017-05-31 The Procter & Gamble Company Cleaning compositions comprising enzymes
WO2017093318A1 (en) 2015-12-01 2017-06-08 Novozymes A/S Methods for producing lipases
WO2017112016A1 (en) 2015-12-22 2017-06-29 Milliken & Company Occult particles for use in granular laundry care compositions
EP3196302A1 (en) 2008-02-14 2017-07-26 Danisco US Inc. Small enzyme-containing granules
US9796952B2 (en) 2012-09-25 2017-10-24 The Procter & Gamble Company Laundry care compositions with thiazolium dye
WO2017192692A1 (en) 2016-05-03 2017-11-09 Danisco Us Inc Protease variants and uses thereof
WO2017192300A1 (en) 2016-05-05 2017-11-09 Danisco Us Inc Protease variants and uses thereof
WO2017210295A1 (en) 2016-05-31 2017-12-07 Danisco Us Inc. Protease variants and uses thereof
WO2017219011A1 (en) 2016-06-17 2017-12-21 Danisco Us Inc Protease variants and uses thereof
US9856439B2 (en) 2010-11-12 2018-01-02 The Procter & Gamble Company Thiophene azo dyes and laundry care compositions containing the same
WO2018015295A1 (en) 2016-07-18 2018-01-25 Novozymes A/S Lipase variants, polynucleotides encoding same and the use thereof
WO2018084930A1 (en) 2016-11-03 2018-05-11 Milliken & Company Leuco triphenylmethane colorants as bluing agents in laundry care compositions
WO2018089211A1 (en) 2016-11-08 2018-05-17 Ecolab Usa Inc. Non-aqueous cleaner for vegetable oil soils
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
WO2018118917A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Protease variants and uses thereof
WO2018118950A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
WO2018169750A1 (en) 2017-03-15 2018-09-20 Danisco Us Inc Trypsin-like serine proteases and uses thereof
WO2018202846A1 (en) 2017-05-05 2018-11-08 Novozymes A/S Compositions comprising lipase and sulfite
US10143632B2 (en) 2011-04-07 2018-12-04 The Procter And Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
EP3456809A1 (en) 2012-10-04 2019-03-20 Ecolab USA, Inc. Pre-soak technology for laundry and other hard surface cleaning
WO2019063499A1 (en) 2017-09-27 2019-04-04 Novozymes A/S Lipase variants and microcapsule compositions comprising such lipase variants
WO2019108599A1 (en) 2017-11-29 2019-06-06 Danisco Us Inc Subtilisin variants having improved stability
WO2019110462A1 (en) 2017-12-04 2019-06-13 Novozymes A/S Lipase variants and polynucleotides encoding same
WO2019113413A1 (en) 2017-12-08 2019-06-13 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
EP3521434A1 (en) 2014-03-12 2019-08-07 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
WO2019154952A1 (en) 2018-02-08 2019-08-15 Novozymes A/S Lipase variants and compositions thereof
WO2019154951A1 (en) 2018-02-08 2019-08-15 Novozymes A/S Lipases, lipase variants and compositions thereof
WO2019245704A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
WO2019245705A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
EP3587569A1 (en) 2014-03-21 2020-01-01 Danisco US Inc. Serine proteases of bacillus species
WO2020046613A1 (en) 2018-08-30 2020-03-05 Danisco Us Inc Compositions comprising a lipolytic enzyme variant and methods of use thereof
WO2020068486A1 (en) 2018-09-27 2020-04-02 Danisco Us Inc Compositions for medical instrument cleaning
US10610473B2 (en) 2016-03-24 2020-04-07 The Procter And Gamble Company Hair care compositions comprising malodor reduction compositions
WO2020081296A1 (en) 2018-10-18 2020-04-23 Milliken & Company Laundry care compositions comprising polyethyleneimine compounds containing n-halamine and derivatives thereof
WO2020081293A1 (en) 2018-10-18 2020-04-23 Milliken & Company Polyethyleneimine compounds containing n-halamine and derivatives thereof
WO2020081297A1 (en) 2018-10-18 2020-04-23 Milliken & Company Polyethyleneimine compounds containing n-halamine and derivatives thereof
WO2020081299A1 (en) 2018-10-18 2020-04-23 Milliken & Company Articles comprising a textile substrate and polyethyleneimine compounds containing n-halamine
WO2020081301A1 (en) 2018-10-18 2020-04-23 Milliken & Company Polyethyleneimine compounds containing n-halamine and derivatives thereof
WO2020081294A1 (en) 2018-10-18 2020-04-23 Milliken & Company Polyethyleneimine compounds containing n-halamine and derivatives thereof
WO2020081300A1 (en) 2018-10-18 2020-04-23 Milliken & Company Process for controlling odor on a textile substrate and polyethyleneimine compounds containing n-halamine
WO2020112599A1 (en) 2018-11-28 2020-06-04 Danisco Us Inc Subtilisin variants having improved stability
EP3696264A1 (en) 2013-07-19 2020-08-19 Danisco US Inc. Compositions and methods comprising a lipolytic enzyme variant
US10792384B2 (en) 2017-12-15 2020-10-06 The Procter & Gamble Company Rolled fibrous structures comprising encapsulated malodor reduction compositions
WO2020242858A1 (en) 2019-05-24 2020-12-03 Danisco Us Inc Subtilisin variants and methods of use
WO2021001400A1 (en) 2019-07-02 2021-01-07 Novozymes A/S Lipase variants and compositions thereof
WO2021030676A1 (en) 2019-08-14 2021-02-18 Ecolab Usa Inc. Methods of cleaning and soil release of highly oil absorbing substrates employing optimized extended chain nonionic surfactants
WO2021037878A1 (en) 2019-08-27 2021-03-04 Novozymes A/S Composition comprising a lipase
WO2021146255A1 (en) 2020-01-13 2021-07-22 Danisco Us Inc Compositions comprising a lipolytic enzyme variant and methods of use thereof
US11096875B2 (en) 2010-04-28 2021-08-24 The Procter & Gamble Company Delivery particle
EP3872174A1 (en) 2015-05-13 2021-09-01 Danisco US Inc. Aprl-clade protease variants and uses thereof
WO2021178099A1 (en) 2020-03-02 2021-09-10 Milliken & Company Composition comprising hueing agent
WO2021178100A1 (en) 2020-03-02 2021-09-10 Milliken & Company Composition comprising hueing agent
WO2021178098A1 (en) 2020-03-02 2021-09-10 Milliken & Company Composition comprising hueing agent
EP3878957A1 (en) 2014-05-27 2021-09-15 Novozymes A/S Methods for producing lipases
EP3929285A2 (en) 2015-07-01 2021-12-29 Novozymes A/S Methods of reducing odor
WO2022010911A1 (en) 2020-07-06 2022-01-13 Ecolab Usa Inc. Foaming mixed alcohol/water compositions comprising a structured alkoxylated siloxane
WO2022010893A1 (en) 2020-07-06 2022-01-13 Ecolab Usa Inc. Foaming mixed alcohol/water compositions comprising a combination of alkyl siloxane and a hydrotrope/solubilizer
WO2022010906A1 (en) 2020-07-06 2022-01-13 Ecolab Usa Inc. Peg-modified castor oil based compositions for microemulsifying and removing multiple oily soils
EP3950939A2 (en) 2015-07-06 2022-02-09 Novozymes A/S Lipase variants and polynucleotides encoding same
WO2022090361A2 (en) 2020-10-29 2022-05-05 Novozymes A/S Lipase variants and compositions comprising such lipase variants
WO2022103725A1 (en) 2020-11-13 2022-05-19 Novozymes A/S Detergent composition comprising a lipase
US11447762B2 (en) 2010-05-06 2022-09-20 Danisco Us Inc. Bacillus lentus subtilisin protease variants and compositions comprising the same
WO2022197295A1 (en) 2021-03-17 2022-09-22 Milliken & Company Polymeric colorants with reduced staining
WO2023017794A1 (en) 2021-08-10 2023-02-16 株式会社日本触媒 Polyalkylene-oxide-containing compound
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules
US11679065B2 (en) 2020-02-27 2023-06-20 The Procter & Gamble Company Compositions with sulfur having enhanced efficacy and aesthetics
WO2023114939A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114932A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114936A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023116569A1 (en) 2021-12-21 2023-06-29 Novozymes A/S Composition comprising a lipase and a booster
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
US11819474B2 (en) 2020-12-04 2023-11-21 The Procter & Gamble Company Hair care compositions comprising malodor reduction materials
WO2023247664A2 (en) 2022-06-24 2023-12-28 Novozymes A/S Lipase variants and compositions comprising such lipase variants
WO2024020445A1 (en) 2022-07-20 2024-01-25 Ecolab Usa Inc. Novel nonionic extended surfactants, compositions and methods of use thereof
US11904036B2 (en) 2017-10-10 2024-02-20 The Procter & Gamble Company Sulfate free clear personal cleansing composition comprising low inorganic salt
WO2024050343A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Subtilisin variants and methods related thereto
WO2024050346A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Detergent compositions and methods related thereto
WO2024050339A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Mannanase variants and methods of use
US11980679B2 (en) 2019-12-06 2024-05-14 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
WO2024102698A1 (en) 2022-11-09 2024-05-16 Danisco Us Inc. Subtilisin variants and methods of use
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
WO2024121057A1 (en) 2022-12-05 2024-06-13 Novozymes A/S A composition for removing body grime
WO2024163584A1 (en) 2023-02-01 2024-08-08 Danisco Us Inc. Subtilisin variants and methods of use
WO2024186819A1 (en) 2023-03-06 2024-09-12 Danisco Us Inc. Subtilisin variants and methods of use
US12227720B2 (en) 2020-10-16 2025-02-18 The Procter & Gamble Company Consumer product compositions with at least two encapsulate populations
WO2025085351A1 (en) 2023-10-20 2025-04-24 Danisco Us Inc. Subtilisin variants and methods of use
WO2025133314A1 (en) 2023-12-21 2025-06-26 Heubach Holding Switzerland Ag (Ltd) Polymeric dyes with enhanced biodegradability containing polycarboxylic acids, amino acids, polyamino acids and/or peptide building blocks
US12398348B2 (en) 2020-10-16 2025-08-26 The Procter & Gamble Company Consumer product compositions comprising a population of encapsulates
EP4617327A1 (en) 2024-03-13 2025-09-17 Heubach Holding Switzerland AG (Ltd) Polymeric dyes with enhanced biodegradability containing saccharide or polysaccharide building blocks
US12427099B2 (en) 2020-11-23 2025-09-30 The Procter & Gamble Company Personal care composition
US12458575B2 (en) 2021-12-09 2025-11-04 The Procter & Gamble Company Sulfate free personal cleansing composition comprising effective preservation
US12486478B2 (en) 2020-10-16 2025-12-02 The Procter & Gamble Company Consumer products comprising delivery particles with high core:wall ratios

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985569B2 (en) 2003-11-19 2011-07-26 Danisco Us Inc. Cellulomonas 69B4 serine protease variants
EP2694017B1 (en) 2011-04-07 2019-05-22 The Procter and Gamble Company Personal cleansing compositions with increased deposition of polyacrylate microcapsules
CN103458871B (en) 2011-04-07 2015-05-13 宝洁公司 Deposited conditioner composition with enhanced polyacrylate microcapsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA981883B (en) * 1997-03-07 1998-09-01 Univ Kansas Catalysts and methods for catalytic oxidation
CA2282477C (en) * 1997-03-07 2004-11-30 The Procter & Gamble Company Improved methods of making cross-bridged macropolycycles

Cited By (436)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002026267A3 (en) * 2000-09-25 2003-04-03 Procter & Gamble Manganes complexes for magnetic resonance imaging
US7312327B2 (en) 2001-09-28 2007-12-25 Centre National De La Recherche Scientifique (C.N.R.S.) Method of preparing nitrogen macrocycles
FR2830253A1 (en) * 2001-09-28 2003-04-04 Air Liquide NEW PROCESS FOR THE PREPARATION OF C-FUNCTIONALIZED NITROGEN MACROCYCLES AND NEW INTERMEDIATES OBTAINED
WO2003029228A1 (en) * 2001-09-28 2003-04-10 Centre National De La Recherche Scientifique (C.N.R.S) Novel method of preparing nitrogen macrocycles
US8246854B2 (en) 2002-06-06 2012-08-21 The Procter & Gamble Company Organic catalyst with enhanced solubility
US7557076B2 (en) 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US7169744B2 (en) 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US8147563B2 (en) 2002-06-06 2012-04-03 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US8021437B2 (en) 2002-06-06 2011-09-20 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatiblity
US7507700B2 (en) 2002-06-06 2009-03-24 The Procter & Gamble Company Organic catalyst with enhanced solubility
US7994109B2 (en) 2002-06-06 2011-08-09 The Procter & Gamble Company Organic catalyst with enhanced solubility
WO2005000823A1 (en) * 2003-06-13 2005-01-06 Centre National De La Recherche Scientifique (C.N.R.S.) Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cyclene and functionalised cyclenes
FR2856063A1 (en) * 2003-06-13 2004-12-17 Air Liquide 1,4,7,10-Tetraaza-cyclododecane production, e.g. for use in production of medical imaging contrast agents, from triethylene tetramine or ethylene diamine via new or known tetracyclic bis-aminal intermediates
US7659393B2 (en) 2003-06-13 2010-02-09 Centre National De La Recherche Scientifique (C.N.R.S.) Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cyclene and functionalised cyclenes
US8535927B1 (en) 2003-11-19 2013-09-17 Danisco Us Inc. Micrococcineae serine protease polypeptides and compositions thereof
EP2664670A1 (en) 2003-12-03 2013-11-20 Danisco US Inc. Perhydrolase
EP2295554A2 (en) 2003-12-03 2011-03-16 Genencor International, Inc. Perhydrolase
EP2292743A2 (en) 2003-12-03 2011-03-09 Genencor International, Inc. Perhydrolase
US9282746B2 (en) 2003-12-03 2016-03-15 Danisco Us Inc. Perhydrolase
US7671005B2 (en) 2004-02-13 2010-03-02 The Procter & Gamble Company Active containing delivery particle
US7425527B2 (en) 2004-06-04 2008-09-16 The Procter & Gamble Company Organic activator
US7846268B2 (en) 2004-11-19 2010-12-07 The Procter & Gamble Company Whiteness perception compositions comprising a dye-polymer conjugate
US7686892B2 (en) 2004-11-19 2010-03-30 The Procter & Gamble Company Whiteness perception compositions
US7504371B2 (en) 2005-06-17 2009-03-17 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
EP1754781A1 (en) 2005-08-19 2007-02-21 The Procter and Gamble Company A solid laundry detergent composition comprising anionic detersive surfactant and a calcium-augmented technology
EP2177259A2 (en) 2005-09-01 2010-04-21 The Procter and Gamble Company Method of processing materials
EP2327472A1 (en) 2005-09-01 2011-06-01 The Procter & Gamble Company Method of processing materials
US8460792B2 (en) 2005-09-27 2013-06-11 The Procter & Gamble Company Microcapsule and method of producing same
US7901772B2 (en) 2005-09-27 2011-03-08 The Procter & Gamble Company Microcapsule and method of producing same
WO2007044993A2 (en) 2005-10-12 2007-04-19 Genencor International, Inc. Use and production of storage-stable neutral metalloprotease
EP2390321A1 (en) 2005-10-12 2011-11-30 The Procter & Gamble Company Use and production of storage-stable neutral metalloprotease
US12043853B2 (en) 2005-10-12 2024-07-23 Danisco Us Inc. Use and production of storage-stable neutral metalloprotease
US9334467B2 (en) 2005-10-12 2016-05-10 Danisco Us Inc. Use and production of storage-stable neutral metalloprotease
US8574884B2 (en) 2005-10-12 2013-11-05 Danisco Us Inc. Thermostable neutral metalloproteases
US10577595B2 (en) 2005-10-12 2020-03-03 Danisco Us Inc Use and production of storage-stable neutral metalloprotease
US11091750B2 (en) 2005-10-12 2021-08-17 Danisco Us Inc Use and production of storage-stable neutral metalloprotease
US8114656B2 (en) 2005-10-12 2012-02-14 Danisco Us Inc. Thermostable neutral metalloproteases
WO2007049188A1 (en) 2005-10-24 2007-05-03 The Procter & Gamble Company Fabric care compositions and systems comprising organosilicone microemulsions and methods employing same
US7790666B2 (en) 2006-01-23 2010-09-07 The Procter & Gamble Company Detergent compositions
EP2287281A1 (en) 2006-01-23 2011-02-23 The Procter & Gamble Company Lipase and fabric hueing agent containing compositions
EP2251404A1 (en) 2006-01-23 2010-11-17 The Procter & Gamble Company Enzyme and fabric hueing agent containing compositions
EP3101111A1 (en) 2006-01-23 2016-12-07 The Procter and Gamble Company Enzyme and fabric hueing agent containing compositions
EP3101110A1 (en) 2006-01-23 2016-12-07 The Procter and Gamble Company Enzyme and fabric hueing agent containing compositions
EP2248882A1 (en) 2006-01-23 2010-11-10 The Procter and Gamble Company Enzyme and fabric hueing agent containing compositions
EP2248883A1 (en) 2006-01-23 2010-11-10 The Procter and Gamble Company Enzyme and fabric hueing agent containing compositions
US8722611B2 (en) 2006-01-23 2014-05-13 The Procter & Gamble Company Enzyme and fabric hueing agent containing compositions
EP2253696A1 (en) 2006-01-23 2010-11-24 The Procter and Gamble Company Enzyme and fabric hueing agent containing compositions
EP2305787A2 (en) 2006-02-28 2011-04-06 The Procter & Gamble Company Compositions comprising benefit agent containing delivery particles
WO2007100501A2 (en) 2006-02-28 2007-09-07 Appleton Papers Inc. Benefit agent containing delivery particle
WO2007144856A2 (en) 2006-06-16 2007-12-21 The Procter & Gamble Company Cleaning and / or treatment compositions comprising mutant alpha-amylases
US7629158B2 (en) 2006-06-16 2009-12-08 The Procter & Gamble Company Cleaning and/or treatment compositions
EP2301517A1 (en) 2006-08-01 2011-03-30 The Procter & Gamble Company Benefit agent containing delivery particle
WO2008066773A2 (en) 2006-11-22 2008-06-05 The Procter & Gamble Company Benefit agent- containing delivery particle
US7968510B2 (en) 2006-11-22 2011-06-28 The Procter & Gamble Company Benefit agent containing delivery particle
EP2431457A1 (en) 2006-11-22 2012-03-21 The Procter & Gamble Company Benefit agent containing delivery particle
EP2845896A1 (en) 2006-11-22 2015-03-11 The Procter and Gamble Company Benefit agent containing delivery particle
EP2557148A1 (en) 2006-11-22 2013-02-13 Appleton Papers Inc. Benefit agent containing delivery particle
EP2418267A1 (en) 2006-11-22 2012-02-15 The Procter & Gamble Company Benefit agent containing delivery particle
USRE45538E1 (en) 2006-11-22 2015-06-02 The Procter & Gamble Company Benefit agent containing delivery particle
US8367598B2 (en) 2007-01-19 2013-02-05 The Procter & Gamble Company Whitening agents for cellulosic subtrates
US11198838B2 (en) 2007-01-19 2021-12-14 The Procter & Gamble Company Whitening agents for cellulosic substrates
US8703688B2 (en) 2007-01-19 2014-04-22 The Procter & Gamble Company Whitening agents for cellulosic substrates
US8247364B2 (en) 2007-01-19 2012-08-21 The Procter & Gamble Company Whitening agents for cellulosic substrates
US10526566B2 (en) 2007-01-19 2020-01-07 The Procter & Gamble Company Whitening agents for cellulosic substrates
US11946025B2 (en) 2007-01-19 2024-04-02 The Procter & Gamble Company Whitening agents for cellulosic substrates
US8450259B2 (en) 2007-02-15 2013-05-28 The Procter & Gamble Company Benefit agent delivery compositions
US8278230B2 (en) 2007-06-05 2012-10-02 The Procter & Gamble Company Perfume systems
WO2008152543A1 (en) 2007-06-11 2008-12-18 The Procter & Gamble Company Benefit agent containing delivery particle
US8940395B2 (en) 2007-06-11 2015-01-27 The Procter & Gamble Company Benefit agent containing delivery particle
US9969961B2 (en) 2007-06-11 2018-05-15 The Procter & Gamble Company Benefit agent containing delivery particle
US8021436B2 (en) 2007-09-27 2011-09-20 The Procter & Gamble Company Cleaning and/or treatment compositions comprising a xyloglucan conjugate
EP2048589A2 (en) 2007-10-03 2009-04-15 The Procter and Gamble Company Modeling systems for consumer goods
EP2845900A1 (en) 2007-11-01 2015-03-11 Danisco US Inc. Production of thermolysin and variants thereof, and use in liquid detergents
US8569034B2 (en) 2007-11-01 2013-10-29 Danisco Us Inc. Thermolysin variants and detergent compositions therewith
US9976134B2 (en) 2007-11-01 2018-05-22 Danisco Us Inc. Thermolysin variants
US7854770B2 (en) 2007-12-04 2010-12-21 The Procter & Gamble Company Detergent composition comprising a surfactant system and a pyrophosphate
EP2071017A1 (en) 2007-12-04 2009-06-17 The Procter and Gamble Company Detergent composition
US8512418B2 (en) 2008-01-04 2013-08-20 The Procter & Gamble Company Enzyme and fabric hueing agent containing compositions
US8580720B2 (en) 2008-01-04 2013-11-12 The Procter & Gamble Company Laundry detergent composition comprising a glycosyl hydrolase and a benefit agent containing delivery particle
EP2083065A1 (en) 2008-01-22 2009-07-29 The Procter and Gamble Company Colour-Care Composition
US8048412B2 (en) 2008-02-11 2011-11-01 Danisco Us Inc. Enzyme with microbial lysis activity from Trichoderma reesei
EP3196302A1 (en) 2008-02-14 2017-07-26 Danisco US Inc. Small enzyme-containing granules
EP3067410A2 (en) 2008-02-15 2016-09-14 The Procter and Gamble Company Cleaning compositions
US7910538B2 (en) 2008-06-04 2011-03-22 The Procter & Gamble Company Detergent composition
EP3095859A1 (en) 2008-06-06 2016-11-23 Danisco US Inc. Compositions and methods comprising variant microbial proteases
EP2578679A1 (en) 2008-06-06 2013-04-10 Danisco US Inc. Compositions and methods comprising variant microbial proteases
US10563189B2 (en) 2008-06-06 2020-02-18 The Procter & Gamble Company Compositions and methods comprising variant microbial proteases
EP2578680A1 (en) 2008-06-06 2013-04-10 Danisco US Inc. Compositions and methods comprising variant microbial proteases
US12448616B2 (en) 2008-06-06 2025-10-21 Danisco Us Inc. Compositions and methods comprising variant microbial proteases
EP2947147A2 (en) 2008-06-06 2015-11-25 Danisco US Inc. Compositions and methods comprising variant microbial proteases
US12410420B2 (en) 2008-06-06 2025-09-09 Danisco Us Inc. Compositions and methods comprising variant microbial proteases
EP3173479A1 (en) 2008-06-06 2017-05-31 Danisco US Inc. Compositions and methods comprising variant microbial proteases
WO2009149144A2 (en) 2008-06-06 2009-12-10 Danisco Us Inc. Compositions and methods comprising variant microbial proteases
US7947643B2 (en) 2008-06-20 2011-05-24 The Procter & Gamble Company Laundry composition comprising a substituted polysaccharide
EP2135933A1 (en) 2008-06-20 2009-12-23 The Procter and Gamble Company Laundry composition
EP2272941A2 (en) 2008-06-20 2011-01-12 The Procter and Gamble Company Laundry composition
EP2135932A1 (en) 2008-06-20 2009-12-23 The Procter and Gamble Company Laundry composition
WO2010014172A2 (en) 2008-07-30 2010-02-04 Appleton Papers Inc. Delivery particle
US10155919B2 (en) 2008-07-30 2018-12-18 The Procter & Gamble Company Delivery particle
EP2166077A1 (en) 2008-09-12 2010-03-24 The Procter and Gamble Company Particles comprising a hueing dye
EP2163608A1 (en) 2008-09-12 2010-03-17 The Procter & Gamble Company Laundry particle made by extrusion comprising a hueing dye and fatty acid soap
EP2166078A1 (en) 2008-09-12 2010-03-24 The Procter & Gamble Company Laundry particle made by extrusion comprising a hueing dye
US8153579B2 (en) 2008-09-12 2012-04-10 The Procter & Gamble Company Laundry composition
US8183197B2 (en) 2008-09-12 2012-05-22 The Procter & Gamble Company Particles comprising a hueing dye
US9243215B2 (en) 2008-11-07 2016-01-26 The Procter & Gamble Company Benefit agent containing delivery particle
US8530219B2 (en) 2008-11-11 2013-09-10 Danisco Us Inc. Compositions and methods comprising a subtilisin variant
US8753861B2 (en) 2008-11-11 2014-06-17 Danisco Us Inc. Protease comprising one or more combinable mutations
EP2589651A2 (en) 2008-11-11 2013-05-08 Danisco US Inc. Compositions and methods comprising serine protease variants
US8183024B2 (en) 2008-11-11 2012-05-22 Danisco Us Inc. Compositions and methods comprising a subtilisin variant
US10093887B2 (en) 2008-11-11 2018-10-09 Danisco Us Inc. Compositions and methods comprising serine protease variants
US9434915B2 (en) 2008-11-11 2016-09-06 Danisco Us Inc. Compositions and methods comprising a subtilisin variant
EP3031894A1 (en) 2008-11-11 2016-06-15 Danisco US Inc. Proteases comprising one or more combinable mutations
EP2647692A2 (en) 2008-11-11 2013-10-09 Danisco US Inc. Compositions and methods comprising serine protease variants
US8431520B2 (en) 2008-12-01 2013-04-30 The Procter & Gamble Company Perfume systems
US8754028B2 (en) 2008-12-16 2014-06-17 The Procter & Gamble Company Perfume systems
WO2010114753A1 (en) 2009-04-02 2010-10-07 The Procter & Gamble Company Composition comprising delivery particles
WO2011002864A1 (en) 2009-06-30 2011-01-06 The Procter & Gamble Company Aminosilicone containing detergent compositions and methods of using same
WO2011002825A1 (en) 2009-06-30 2011-01-06 The Procter & Gamble Company Rinse added aminosilicone containing compositions and methods of using same
WO2011005904A1 (en) 2009-07-09 2011-01-13 The Procter & Gamble Company Detergent composition
EP3336164A1 (en) 2009-07-10 2018-06-20 The Procter & Gamble Company Compositions containing benefit agent delivery particles
WO2011005943A1 (en) 2009-07-10 2011-01-13 The Procter & Gamble Company Compositions containing benefit agent delivery particles
WO2011005932A1 (en) 2009-07-10 2011-01-13 The Procter & Gamble Company Compositions containing benefit agent delivery particles
WO2011016958A2 (en) 2009-07-27 2011-02-10 The Procter & Gamble Company Detergent composition
US8759275B2 (en) 2009-11-06 2014-06-24 The Proctor & Gamble Company High-efficiency perfume capsules
US8357649B2 (en) 2009-11-06 2013-01-22 The Procter & Gamble Company Delivery particle
WO2011056934A1 (en) 2009-11-06 2011-05-12 The Procter & Gamble Company High efficiency capsules comprising benefit agent
EP3255135A1 (en) 2009-11-06 2017-12-13 The Procter & Gamble Company High-efficiency perfume capsules
WO2011056935A1 (en) 2009-11-06 2011-05-12 The Procter & Gamble Company Delivery particle
WO2011056904A1 (en) 2009-11-06 2011-05-12 The Procter & Gamble Company High efficiency particle comprising benefit agent
US9011887B2 (en) 2009-11-06 2015-04-21 The Procter & Gamble Company Encapsulate with a cationic and anionic polymeric coating
EP4159833A2 (en) 2009-12-09 2023-04-05 The Procter & Gamble Company Fabric and home care products
EP3434764A2 (en) 2009-12-09 2019-01-30 The Procter & Gamble Company Fabric and home care products
WO2011072117A1 (en) 2009-12-09 2011-06-16 The Procter & Gamble Company Fabric and home care products
WO2011072099A2 (en) 2009-12-09 2011-06-16 Danisco Us Inc. Compositions and methods comprising protease variants
EP3190183A1 (en) 2009-12-09 2017-07-12 Danisco US Inc. Compositions and methods comprising protease variants
US8728790B2 (en) 2009-12-09 2014-05-20 Danisco Us Inc. Compositions and methods comprising protease variants
EP3599279A1 (en) 2009-12-09 2020-01-29 Danisco US Inc. Compositions and methods comprising protease variants
US9157052B2 (en) 2009-12-09 2015-10-13 Danisco Us Inc. Methods for cleaning using a variant protease derived from subtilisin
EP3309245A1 (en) 2009-12-18 2018-04-18 The Procter & Gamble Company Encapsulates
WO2011075551A1 (en) 2009-12-18 2011-06-23 The Procter & Gamble Company Perfumes and perfume encapsulates
US8524650B2 (en) 2009-12-18 2013-09-03 The Procter & Gamble Company Encapsulates
WO2011075556A1 (en) 2009-12-18 2011-06-23 The Procter & Gamble Company Composition comprising encapsulates, and process for making them
US9994801B2 (en) 2009-12-18 2018-06-12 The Procter & Gamble Company Encapsulates
US8741609B2 (en) 2009-12-21 2014-06-03 Danisco Us Inc. Detergent compositions containing Geobacillus stearothermophilus lipase and methods of use thereof
WO2011084599A1 (en) 2009-12-21 2011-07-14 Danisco Us Inc. Detergent compositions containing bacillus subtilis lipase and methods of use thereof
WO2011084417A1 (en) 2009-12-21 2011-07-14 Danisco Us Inc. Detergent compositions containing geobacillus stearothermophilus lipase and methods of use thereof
WO2011084412A1 (en) 2009-12-21 2011-07-14 Danisco Us Inc. Detergent compositions containing thermobifida fusca lipase and methods of use thereof
WO2011090957A2 (en) 2010-01-21 2011-07-28 The Procter & Gamble Company Process of preparing a particle
WO2011100420A1 (en) 2010-02-12 2011-08-18 The Procter & Gamble Company Benefit compositions comprising crosslinked polyglycerol esters
WO2011100500A1 (en) 2010-02-12 2011-08-18 The Procter & Gamble Company Benefit compositions comprising polyglycerol esters
WO2011100405A1 (en) 2010-02-12 2011-08-18 The Procter & Gamble Company Benefit compositions comprising crosslinked polyglycerol esters
WO2011100411A1 (en) 2010-02-12 2011-08-18 The Procter & Gamble Company Benefit compositions comprising polyglycerol esters
WO2011109322A1 (en) 2010-03-04 2011-09-09 The Procter & Gamble Company Detergent composition
WO2011130222A2 (en) 2010-04-15 2011-10-20 Danisco Us Inc. Compositions and methods comprising variant proteases
WO2011133306A1 (en) 2010-04-19 2011-10-27 The Procter & Gamble Company Detergent composition
US11096875B2 (en) 2010-04-28 2021-08-24 The Procter & Gamble Company Delivery particle
US12133906B2 (en) 2010-04-28 2024-11-05 The Procter & Gamble Company Delivery particle
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US11447762B2 (en) 2010-05-06 2022-09-20 Danisco Us Inc. Bacillus lentus subtilisin protease variants and compositions comprising the same
WO2011146604A2 (en) 2010-05-18 2011-11-24 Milliken & Company Optical brighteners and compositions comprising the same
EP3020768A1 (en) 2010-05-18 2016-05-18 Milliken & Company Optical brighteners and compositions comprising the same
WO2011146602A2 (en) 2010-05-18 2011-11-24 Milliken & Company Optical brighteners and compositions comprising the same
WO2011150138A1 (en) 2010-05-26 2011-12-01 The Procter & Gamble Company Encapsulates
WO2011150157A2 (en) 2010-05-28 2011-12-01 Danisco Us Inc. Detergent compositions containing streptomyces griseus lipase and methods of use thereof
WO2011149871A1 (en) 2010-05-28 2011-12-01 Milliken & Company Colored speckles having delayed release properties
EP3121255A1 (en) 2010-06-22 2017-01-25 The Procter and Gamble Company Perfume systems
WO2011163337A1 (en) 2010-06-22 2011-12-29 The Procter & Gamble Company Perfume systems
EP3121256A1 (en) 2010-06-22 2017-01-25 The Procter and Gamble Company Perfume systems
EP3287511A1 (en) 2010-06-22 2018-02-28 The Procter & Gamble Company Perfume systems
EP3085759A2 (en) 2010-06-22 2016-10-26 The Procter and Gamble Company Perfume systems
WO2011163325A1 (en) 2010-06-22 2011-12-29 The Procter & Gamble Company Perfume systems
EP3301167A1 (en) 2010-06-30 2018-04-04 The Procter & Gamble Company Rinse added aminosilicone containing compositions and methods of using same
WO2012003192A1 (en) 2010-06-30 2012-01-05 The Procter & Gamble Company Rinse added aminosilicone containing compositions and methods of using same
WO2012012494A1 (en) 2010-07-20 2012-01-26 The Procter & Gamble Company Particles with a plurality of coatings
WO2012012475A1 (en) 2010-07-20 2012-01-26 The Procter & Gamble Company Delivery particles with a plurality of cores
WO2012040171A1 (en) 2010-09-20 2012-03-29 The Procter & Gamble Company Non-fluoropolymer surface protection composition
US8633146B2 (en) 2010-09-20 2014-01-21 The Procter & Gamble Company Non-fluoropolymer surface protection composition comprising a polyorganosiloxane-silicone resin mixture
WO2012040130A1 (en) 2010-09-20 2012-03-29 The Procter & Gamble Company Non-fluoropolymer surface protection composition
US8637442B2 (en) 2010-09-20 2014-01-28 The Procter & Gamble Company Non-fluoropolymer surface protection composition comprising a polyorganosiloxane-silicone resin mixture
WO2012040131A2 (en) 2010-09-20 2012-03-29 The Procter & Gamble Company Fabric care formulations and methods
WO2011026154A2 (en) 2010-10-29 2011-03-03 The Procter & Gamble Company Cleaning and/or treatment compositions
WO2012057781A1 (en) 2010-10-29 2012-05-03 The Procter & Gamble Company Cleaning and/or treatment compositions comprising a fungal serine protease
US9856439B2 (en) 2010-11-12 2018-01-02 The Procter & Gamble Company Thiophene azo dyes and laundry care compositions containing the same
US10435651B2 (en) 2010-11-12 2019-10-08 The Procter & Gamble Company Thiophene azo dyes and laundry care compositions containing the same
US10655091B2 (en) 2010-11-12 2020-05-19 The Procter & Gamble Company Thiophene azo dyes and laundry care compositions containing the same
US8889614B2 (en) 2010-12-21 2014-11-18 The Procter & Gamble Company Encapsulates
WO2012085864A1 (en) 2010-12-21 2012-06-28 Procter & Gamble International Operations Sa Encapsulates
EP2468239A1 (en) 2010-12-21 2012-06-27 Procter & Gamble International Operations SA Encapsulates
WO2012116023A1 (en) 2011-02-25 2012-08-30 Milliken & Company Capsules and compositions comprising the same
WO2012116021A1 (en) 2011-02-25 2012-08-30 Milliken & Company Capsules and compositions comprising the same
WO2012116014A1 (en) 2011-02-25 2012-08-30 Milliken & Company Capsules and compositions comprising the same
US10143632B2 (en) 2011-04-07 2018-12-04 The Procter And Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
WO2012142087A1 (en) 2011-04-12 2012-10-18 The Procter & Gamble Company Metal bleach catalysts
US8986970B2 (en) 2011-04-29 2015-03-24 Danisco Us Inc. Detergent compositions containing Bacillus agaradhaerens mannanase and methods of use thereof
US8802388B2 (en) 2011-04-29 2014-08-12 Danisco Us Inc. Detergent compositions containing Bacillus agaradhaerens mannanase and methods of use thereof
WO2012149333A1 (en) 2011-04-29 2012-11-01 Danisco Us Inc. Detergent compositions containing bacillus sp. mannanase and methods of use thereof
WO2012149325A1 (en) 2011-04-29 2012-11-01 Danisco Us Inc. Detergent compositions containing geobacillus tepidamans mannanase and methods of use thereof
WO2012149317A1 (en) 2011-04-29 2012-11-01 Danisco Us Inc. Detergent compositions containing bacillus agaradhaerens mannanase and methods of use thereof
WO2012151534A1 (en) 2011-05-05 2012-11-08 Danisco Us Inc. Compositions and methods comprising serine protease variants
EP3486319A2 (en) 2011-05-05 2019-05-22 Danisco US Inc. Compositions and methods comprising serine protease variants
EP4230735A1 (en) 2011-05-05 2023-08-23 Danisco US Inc. Compositions and methods comprising serine protease variants
WO2012151480A2 (en) 2011-05-05 2012-11-08 The Procter & Gamble Company Compositions and methods comprising serine protease variants
US9856466B2 (en) 2011-05-05 2018-01-02 Danisco Us Inc. Compositions and methods comprising serine protease variants
EP2537918A1 (en) 2011-06-20 2012-12-26 The Procter & Gamble Company Consumer products with lipase comprising coated particles
WO2013003025A1 (en) 2011-06-20 2013-01-03 The Procter & Gamble Company Consumer products with lipase comprising coated particles
US9309487B2 (en) 2011-06-23 2016-04-12 The Procter & Gamble Company Perfume systems
US9822327B2 (en) 2011-06-23 2017-11-21 The Procter & Gamble Company Perfume systems
US8912350B2 (en) 2011-06-23 2014-12-16 The Procter & Gamble Company Perfume systems
WO2012177357A1 (en) 2011-06-23 2012-12-27 The Procter & Gamble Company Perfume systems
WO2013022949A1 (en) 2011-08-10 2013-02-14 The Procter & Gamble Company Encapsulates
WO2013033318A1 (en) 2011-08-31 2013-03-07 Danisco Us Inc. Compositions and methods comprising a lipolytic enzyme variant
WO2013040114A1 (en) 2011-09-13 2013-03-21 The Procter & Gamble Company Encapsulates
EP2581438A1 (en) 2011-10-12 2013-04-17 The Procter and Gamble Company Detergent composition
WO2013055903A1 (en) 2011-10-12 2013-04-18 The Procter & Gamble Company Detergent composition
WO2013096653A1 (en) 2011-12-22 2013-06-27 Danisco Us Inc. Compositions and methods comprising a lipolytic enzyme variant
EP3109307A2 (en) 2012-01-18 2016-12-28 The Procter and Gamble Company Perfume systems
EP3109308A2 (en) 2012-01-18 2016-12-28 The Procter and Gamble Company Perfume systems
EP3109309A2 (en) 2012-01-18 2016-12-28 The Procter and Gamble Company Perfume systems
US9441185B2 (en) 2012-01-18 2016-09-13 The Procter & Gamble Company Perfume systems
US10144903B2 (en) 2012-01-18 2018-12-04 The Procter & Gamble Company Perfume systems
WO2013109798A2 (en) 2012-01-18 2013-07-25 The Procter & Gamble Company Perfume systems
EP3101112A2 (en) 2012-01-18 2016-12-07 The Procter and Gamble Company Perfume systems
EP3696265A2 (en) 2012-02-03 2020-08-19 Novozymes A/S Lipase variants and polynucleotides encoding same
WO2013113622A1 (en) 2012-02-03 2013-08-08 Novozymes A/S Lipase variants and polynucleotides encoding same
EP4570895A2 (en) 2012-02-03 2025-06-18 Novozymes A/S Lipase variants and polynucleotides encoding same
EP3211074A2 (en) 2012-02-03 2017-08-30 Novozymes A/S Lipase variants and polynucleotides encoding same
EP2623586A2 (en) 2012-02-03 2013-08-07 The Procter & Gamble Company Compositions and methods for surface treatment with lipases
WO2013116261A2 (en) 2012-02-03 2013-08-08 The Procter & Gamble Company Compositions and methods for surface treatment with lipases
WO2013006871A2 (en) 2012-02-13 2013-01-10 Milliken & Company Laundry care compositions containing dyes
WO2013142495A1 (en) 2012-03-19 2013-09-26 Milliken & Company Carboxylate dyes
WO2013142486A1 (en) 2012-03-19 2013-09-26 The Procter & Gamble Company Laundry care compositions containing dyes
WO2013148639A1 (en) 2012-03-26 2013-10-03 The Procter & Gamble Company Cleaning compositions comprising ph-switchable amine surfactants
WO2013149858A1 (en) 2012-04-02 2013-10-10 Novozymes A/S Lipase variants and polynucleotides encoding same
WO2013171241A1 (en) 2012-05-16 2013-11-21 Novozymes A/S Compositions comprising lipase and methods of use thereof
EP2674476A1 (en) 2012-06-11 2013-12-18 The Procter & Gamble Company Detergent composition
WO2013188331A1 (en) 2012-06-11 2013-12-19 The Procter & Gamble Company Detergent composition
EP2674475A1 (en) 2012-06-11 2013-12-18 The Procter & Gamble Company Detergent composition
US9796952B2 (en) 2012-09-25 2017-10-24 The Procter & Gamble Company Laundry care compositions with thiazolium dye
WO2014055245A1 (en) 2012-10-01 2014-04-10 The Procter & Gamble Company Methods of treating a surface and compositions for use therein
EP2712915A1 (en) 2012-10-01 2014-04-02 The Procter and Gamble Company Methods of treating a surface and compositions for use therein
EP3456809A1 (en) 2012-10-04 2019-03-20 Ecolab USA, Inc. Pre-soak technology for laundry and other hard surface cleaning
WO2014059360A1 (en) 2012-10-12 2014-04-17 Danisco Us Inc. Compositions and methods comprising a lipolytic enzyme variant
US9095787B2 (en) 2012-10-24 2015-08-04 The Procter & Gamble Company Compositions comprising anti-foams
US9133421B2 (en) 2012-10-24 2015-09-15 The Procter & Gamble Company Compositions comprising anti-foams
WO2014066308A1 (en) 2012-10-24 2014-05-01 The Procter & Gamble Company Anti foam compositions comprising aryl bearing polyorganosilicons
WO2014066309A1 (en) 2012-10-24 2014-05-01 The Procter & Gamble Company Anti foam compositions comprising partly phenyl bearing polyorganosilicons
WO2014071410A1 (en) 2012-11-05 2014-05-08 Danisco Us Inc. Compositions and methods comprising thermolysin protease variants
WO2014100018A1 (en) 2012-12-19 2014-06-26 Danisco Us Inc. Novel mannanase, compositions and methods of use thereof
WO2014138141A1 (en) 2013-03-05 2014-09-12 The Procter & Gamble Company Mixed sugar compositions
WO2014147127A1 (en) 2013-03-21 2014-09-25 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
WO2014184164A1 (en) 2013-05-14 2014-11-20 Novozymes A/S Detergent compositions
EP2806018A1 (en) 2013-05-20 2014-11-26 The Procter & Gamble Company Encapsulates
WO2014189980A1 (en) 2013-05-20 2014-11-27 Pgiosa Encapsulates
WO2014189906A2 (en) 2013-05-20 2014-11-27 The Procter & Gamble Company Encapsulates
EP2808372A1 (en) 2013-05-28 2014-12-03 The Procter and Gamble Company Surface treatment compositions comprising photochromic dyes
WO2014193859A1 (en) 2013-05-28 2014-12-04 The Procter & Gamble Company Surface treatment compositions comprising photochromic dyes
EP3699256A1 (en) 2013-05-28 2020-08-26 The Procter & Gamble Company Surface treatment compositions comprising photochromic dyes
EP3260538A1 (en) 2013-05-29 2017-12-27 Danisco US Inc. Novel metalloproteases
EP3636662A1 (en) 2013-05-29 2020-04-15 Danisco US Inc. Novel metalloproteases
WO2014194054A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194032A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194034A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
EP3882346A1 (en) 2013-05-29 2021-09-22 Danisco US Inc. Novel metalloproteases
WO2014194117A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
EP4159854A1 (en) 2013-05-29 2023-04-05 Danisco US Inc Novel metalloproteases
WO2015004102A1 (en) 2013-07-09 2015-01-15 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
EP3696264A1 (en) 2013-07-19 2020-08-19 Danisco US Inc. Compositions and methods comprising a lipolytic enzyme variant
WO2015038792A1 (en) 2013-09-12 2015-03-19 Danisco Us Inc. Compositions and methods comprising lg12-clade protease variants
EP3653707A1 (en) 2013-09-12 2020-05-20 Danisco US Inc. Compositions and methods comprising lg12-clade protease variants
EP3339377A1 (en) 2013-09-18 2018-06-27 Milliken & Company Laundry care composition comprising carboxylate dye
WO2015042086A1 (en) 2013-09-18 2015-03-26 The Procter & Gamble Company Laundry care composition comprising carboxylate dye
WO2015042209A1 (en) 2013-09-18 2015-03-26 The Procter & Gamble Company Laundry care compositions containing thiophene azo carboxylate dyes
WO2015042087A1 (en) 2013-09-18 2015-03-26 The Procter & Gamble Company Laundry care composition comprising carboxylate dye
WO2015041887A2 (en) 2013-09-18 2015-03-26 Milliken & Company Laundry care composition comprising carboxylate dye
EP4047058A1 (en) 2013-09-18 2022-08-24 Milliken & Company Laundry care composition comprising a carboxylate dye
WO2015089441A1 (en) 2013-12-13 2015-06-18 Danisco Us Inc. Serine proteases of bacillus species
EP3553173A1 (en) 2013-12-13 2019-10-16 Danisco US Inc. Serine proteases of the bacillus gibsonii-clade
WO2015089447A1 (en) 2013-12-13 2015-06-18 Danisco Us Inc. Serine proteases of the bacillus gibsonii-clade
EP3514230A1 (en) 2013-12-13 2019-07-24 Danisco US Inc. Serine proteases of bacillus species
EP3910057A1 (en) 2013-12-13 2021-11-17 Danisco US Inc. Serine proteases of the bacillus gibsonii-clade
WO2015112340A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Method of treating textile fabrics
WO2015112338A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Method of treating textile fabrics
WO2015112339A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Fabric treatment composition
WO2015112341A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Fabric treatment composition
EP3521434A1 (en) 2014-03-12 2019-08-07 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
EP4155398A1 (en) 2014-03-21 2023-03-29 Danisco US Inc. Serine proteases of bacillus species
EP3587569A1 (en) 2014-03-21 2020-01-01 Danisco US Inc. Serine proteases of bacillus species
WO2015158237A1 (en) 2014-04-15 2015-10-22 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
WO2015171592A1 (en) 2014-05-06 2015-11-12 Milliken & Company Laundry care compositions
EP3760713A2 (en) 2014-05-27 2021-01-06 Novozymes A/S Lipase variants and polynucleotides encoding same
WO2015181119A2 (en) 2014-05-27 2015-12-03 Novozymes A/S Lipase variants and polynucleotides encoding same
EP3878957A1 (en) 2014-05-27 2021-09-15 Novozymes A/S Methods for producing lipases
US11334695B2 (en) 2014-09-26 2022-05-17 The Procter & Gamble Company Antiperspirant and deodorant compositions comprising malodor reduction compositions
US10113140B2 (en) 2014-09-26 2018-10-30 The Procter & Gamble Company Freshening compositions and devices comprising same
WO2016049393A1 (en) 2014-09-26 2016-03-31 The Procter & Gamble Company Method of making perfumed goods
US11334694B2 (en) 2014-09-26 2022-05-17 The Procter & Gamble Company Personal care compositions comprising malodor reduction compositions
US10552557B2 (en) 2014-09-26 2020-02-04 The Procter & Gamble Company Freshening compositions and devices comprising same
WO2016061438A1 (en) 2014-10-17 2016-04-21 Danisco Us Inc. Serine proteases of bacillus species
WO2016069557A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases of bacillus species
WO2016069548A2 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069552A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
EP4403631A2 (en) 2014-10-27 2024-07-24 Danisco US Inc. Serine proteases
EP3550017A1 (en) 2014-10-27 2019-10-09 Danisco US Inc. Serine proteases
WO2016069569A2 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069544A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016081437A1 (en) 2014-11-17 2016-05-26 The Procter & Gamble Company Benefit agent delivery compositions
WO2016087401A1 (en) 2014-12-05 2016-06-09 Novozymes A/S Lipase variants and polynucleotides encoding same
EP4067485A2 (en) 2014-12-05 2022-10-05 Novozymes A/S Lipase variants and polynucleotides encoding same
WO2016130521A1 (en) 2015-02-10 2016-08-18 The Procter & Gamble Company Liquid laundry cleaning composition
WO2016145428A1 (en) 2015-03-12 2016-09-15 Danisco Us Inc Compositions and methods comprising lg12-clade protease variants
EP3611259A1 (en) 2015-03-12 2020-02-19 Danisco US Inc. Compositions and methods comprising lg12-clade protease variants
WO2016176241A1 (en) 2015-04-29 2016-11-03 The Procter & Gamble Company Detergent composition
EP3088502A1 (en) 2015-04-29 2016-11-02 The Procter and Gamble Company Method of treating a fabric
EP3088505A1 (en) 2015-04-29 2016-11-02 The Procter and Gamble Company Method of treating a fabric
WO2016176282A1 (en) 2015-04-29 2016-11-03 The Procter & Gamble Company Method of treating a fabric
WO2016176280A1 (en) 2015-04-29 2016-11-03 The Procter & Gamble Company Method of treating a fabric
EP3088503A1 (en) 2015-04-29 2016-11-02 The Procter and Gamble Company Method of treating a fabric
WO2016176296A1 (en) 2015-04-29 2016-11-03 The Procter & Gamble Company Method of laundering a fabric
EP3088506A1 (en) 2015-04-29 2016-11-02 The Procter and Gamble Company Detergent composition
EP3088504A1 (en) 2015-04-29 2016-11-02 The Procter and Gamble Company Method of treating a fabric
WO2016176240A1 (en) 2015-04-29 2016-11-03 The Procter & Gamble Company Method of treating a fabric
EP3674387A1 (en) 2015-04-29 2020-07-01 The Procter & Gamble Company Method of treating a fabric
WO2016178668A1 (en) 2015-05-04 2016-11-10 Milliken & Company Leuco triphenylmethane colorants as bluing agents in laundry care compositions
EP4219704A2 (en) 2015-05-13 2023-08-02 Danisco US Inc Aprl-clade protease variants and uses thereof
EP3872174A1 (en) 2015-05-13 2021-09-01 Danisco US Inc. Aprl-clade protease variants and uses thereof
WO2016184944A1 (en) 2015-05-19 2016-11-24 Novozymes A/S Odor reduction
WO2016202739A1 (en) 2015-06-16 2016-12-22 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
WO2016205755A1 (en) 2015-06-17 2016-12-22 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
EP4234693A2 (en) 2015-06-17 2023-08-30 Danisco US Inc Bacillus gibsonii-clade serine proteases
WO2016205008A1 (en) 2015-06-19 2016-12-22 The Procter & Gamble Company Computer-implemeted method of making perfumed goods
EP3929285A2 (en) 2015-07-01 2021-12-29 Novozymes A/S Methods of reducing odor
EP3950939A2 (en) 2015-07-06 2022-02-09 Novozymes A/S Lipase variants and polynucleotides encoding same
WO2017066413A1 (en) 2015-10-13 2017-04-20 Milliken & Company Novel whitening agents for cellulosic substrates
WO2017065978A1 (en) 2015-10-13 2017-04-20 The Procter & Gamble Company Laundry care compositions comprising whitening agents for cellulosic substrates
WO2017066334A1 (en) 2015-10-13 2017-04-20 Milliken & Company Novel whitening agents for cellulosic substrates
WO2017066343A1 (en) 2015-10-13 2017-04-20 Milliken & Company Novel whitening agents for cellulosic substrates
WO2017065979A1 (en) 2015-10-13 2017-04-20 The Procter & Gamble Company Laundry care compositions comprising whitening agents for cellulosic substrates
WO2017066337A1 (en) 2015-10-13 2017-04-20 Milliken & Company Novel whitening agents for cellulosic substrates
WO2017065977A1 (en) 2015-10-13 2017-04-20 The Procter & Gamble Company Laundry care compositions comprising whitening agents for cellulosic substrates
WO2017079756A1 (en) 2015-11-05 2017-05-11 Danisco Us Inc Paenibacillus and bacillus spp. mannanases
WO2017079751A1 (en) 2015-11-05 2017-05-11 Danisco Us Inc Paenibacillus sp. mannanases
EP4141113A1 (en) 2015-11-05 2023-03-01 Danisco US Inc Paenibacillus sp. mannanases
EP4483721A2 (en) 2015-11-05 2025-01-01 Danisco US Inc. Paenibacillus and bacillus spp. mannanases
WO2017091674A1 (en) 2015-11-26 2017-06-01 The Procter & Gamble Company Liquid detergent compositions comprising protease and encapsulated lipase
EP3173467A1 (en) 2015-11-26 2017-05-31 The Procter & Gamble Company Cleaning compositions comprising enzymes
WO2017093318A1 (en) 2015-12-01 2017-06-08 Novozymes A/S Methods for producing lipases
WO2017112016A1 (en) 2015-12-22 2017-06-29 Milliken & Company Occult particles for use in granular laundry care compositions
US10610473B2 (en) 2016-03-24 2020-04-07 The Procter And Gamble Company Hair care compositions comprising malodor reduction compositions
US11197809B2 (en) 2016-03-24 2021-12-14 The Procter And Gamble Company Hair care compositions comprising malodor reduction compositions
US11197810B2 (en) 2016-03-24 2021-12-14 The Procter And Gamble Company Hair care compositions comprising malodor reduction compositions
WO2017192692A1 (en) 2016-05-03 2017-11-09 Danisco Us Inc Protease variants and uses thereof
EP3845642A1 (en) 2016-05-05 2021-07-07 Danisco US Inc. Protease variants and uses thereof
WO2017192300A1 (en) 2016-05-05 2017-11-09 Danisco Us Inc Protease variants and uses thereof
WO2017210295A1 (en) 2016-05-31 2017-12-07 Danisco Us Inc. Protease variants and uses thereof
EP4151726A1 (en) 2016-06-17 2023-03-22 Danisco US Inc Protease variants and uses thereof
EP4527923A2 (en) 2016-06-17 2025-03-26 Danisco US Inc Protease variants and uses thereof
WO2017219011A1 (en) 2016-06-17 2017-12-21 Danisco Us Inc Protease variants and uses thereof
EP4357453A2 (en) 2016-07-18 2024-04-24 Novozymes A/S Lipase variants, polynucleotides encoding same and the use thereof
WO2018015295A1 (en) 2016-07-18 2018-01-25 Novozymes A/S Lipase variants, polynucleotides encoding same and the use thereof
WO2018084930A1 (en) 2016-11-03 2018-05-11 Milliken & Company Leuco triphenylmethane colorants as bluing agents in laundry care compositions
WO2018089211A1 (en) 2016-11-08 2018-05-17 Ecolab Usa Inc. Non-aqueous cleaner for vegetable oil soils
EP4424805A2 (en) 2016-12-21 2024-09-04 Danisco Us Inc Bacillus gibsonii-clade serine proteases
EP4212622A2 (en) 2016-12-21 2023-07-19 Danisco US Inc. Bacillus gibsonii-clade serine proteases
EP4520820A2 (en) 2016-12-21 2025-03-12 Danisco Us Inc Protease variants and uses thereof
WO2018118950A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
WO2018118917A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Protease variants and uses thereof
WO2018169750A1 (en) 2017-03-15 2018-09-20 Danisco Us Inc Trypsin-like serine proteases and uses thereof
WO2018202846A1 (en) 2017-05-05 2018-11-08 Novozymes A/S Compositions comprising lipase and sulfite
EP4567094A2 (en) 2017-09-27 2025-06-11 Novozymes A/S Lipase variants and microcapsule compositions comprising such lipase variants
WO2019063499A1 (en) 2017-09-27 2019-04-04 Novozymes A/S Lipase variants and microcapsule compositions comprising such lipase variants
US11992540B2 (en) 2017-10-10 2024-05-28 The Procter & Gamble Company Sulfate free personal cleansing composition comprising low inorganic salt
US11904036B2 (en) 2017-10-10 2024-02-20 The Procter & Gamble Company Sulfate free clear personal cleansing composition comprising low inorganic salt
WO2019108599A1 (en) 2017-11-29 2019-06-06 Danisco Us Inc Subtilisin variants having improved stability
WO2019110462A1 (en) 2017-12-04 2019-06-13 Novozymes A/S Lipase variants and polynucleotides encoding same
WO2019113413A1 (en) 2017-12-08 2019-06-13 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
US10792384B2 (en) 2017-12-15 2020-10-06 The Procter & Gamble Company Rolled fibrous structures comprising encapsulated malodor reduction compositions
WO2019154952A1 (en) 2018-02-08 2019-08-15 Novozymes A/S Lipase variants and compositions thereof
WO2019154954A1 (en) 2018-02-08 2019-08-15 Novozymes A/S Lipase variants and compositions thereof
WO2019154951A1 (en) 2018-02-08 2019-08-15 Novozymes A/S Lipases, lipase variants and compositions thereof
WO2019154955A1 (en) 2018-02-08 2019-08-15 Novozymes A/S Lipase variants and compositions thereof
WO2019245704A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
WO2019245705A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
WO2020046613A1 (en) 2018-08-30 2020-03-05 Danisco Us Inc Compositions comprising a lipolytic enzyme variant and methods of use thereof
WO2020068486A1 (en) 2018-09-27 2020-04-02 Danisco Us Inc Compositions for medical instrument cleaning
WO2020081299A1 (en) 2018-10-18 2020-04-23 Milliken & Company Articles comprising a textile substrate and polyethyleneimine compounds containing n-halamine
WO2020081301A1 (en) 2018-10-18 2020-04-23 Milliken & Company Polyethyleneimine compounds containing n-halamine and derivatives thereof
WO2020081300A1 (en) 2018-10-18 2020-04-23 Milliken & Company Process for controlling odor on a textile substrate and polyethyleneimine compounds containing n-halamine
WO2020081296A1 (en) 2018-10-18 2020-04-23 Milliken & Company Laundry care compositions comprising polyethyleneimine compounds containing n-halamine and derivatives thereof
WO2020081293A1 (en) 2018-10-18 2020-04-23 Milliken & Company Polyethyleneimine compounds containing n-halamine and derivatives thereof
WO2020081297A1 (en) 2018-10-18 2020-04-23 Milliken & Company Polyethyleneimine compounds containing n-halamine and derivatives thereof
WO2020081294A1 (en) 2018-10-18 2020-04-23 Milliken & Company Polyethyleneimine compounds containing n-halamine and derivatives thereof
WO2020112599A1 (en) 2018-11-28 2020-06-04 Danisco Us Inc Subtilisin variants having improved stability
WO2020242858A1 (en) 2019-05-24 2020-12-03 Danisco Us Inc Subtilisin variants and methods of use
WO2021001400A1 (en) 2019-07-02 2021-01-07 Novozymes A/S Lipase variants and compositions thereof
WO2021030676A1 (en) 2019-08-14 2021-02-18 Ecolab Usa Inc. Methods of cleaning and soil release of highly oil absorbing substrates employing optimized extended chain nonionic surfactants
WO2021037878A1 (en) 2019-08-27 2021-03-04 Novozymes A/S Composition comprising a lipase
US11980679B2 (en) 2019-12-06 2024-05-14 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
WO2021146255A1 (en) 2020-01-13 2021-07-22 Danisco Us Inc Compositions comprising a lipolytic enzyme variant and methods of use thereof
US11679065B2 (en) 2020-02-27 2023-06-20 The Procter & Gamble Company Compositions with sulfur having enhanced efficacy and aesthetics
WO2021178098A1 (en) 2020-03-02 2021-09-10 Milliken & Company Composition comprising hueing agent
WO2021178100A1 (en) 2020-03-02 2021-09-10 Milliken & Company Composition comprising hueing agent
WO2021178099A1 (en) 2020-03-02 2021-09-10 Milliken & Company Composition comprising hueing agent
WO2022010906A1 (en) 2020-07-06 2022-01-13 Ecolab Usa Inc. Peg-modified castor oil based compositions for microemulsifying and removing multiple oily soils
WO2022010893A1 (en) 2020-07-06 2022-01-13 Ecolab Usa Inc. Foaming mixed alcohol/water compositions comprising a combination of alkyl siloxane and a hydrotrope/solubilizer
WO2022010911A1 (en) 2020-07-06 2022-01-13 Ecolab Usa Inc. Foaming mixed alcohol/water compositions comprising a structured alkoxylated siloxane
US12486478B2 (en) 2020-10-16 2025-12-02 The Procter & Gamble Company Consumer products comprising delivery particles with high core:wall ratios
US12398348B2 (en) 2020-10-16 2025-08-26 The Procter & Gamble Company Consumer product compositions comprising a population of encapsulates
US12227720B2 (en) 2020-10-16 2025-02-18 The Procter & Gamble Company Consumer product compositions with at least two encapsulate populations
WO2022090361A2 (en) 2020-10-29 2022-05-05 Novozymes A/S Lipase variants and compositions comprising such lipase variants
WO2022103725A1 (en) 2020-11-13 2022-05-19 Novozymes A/S Detergent composition comprising a lipase
US12427099B2 (en) 2020-11-23 2025-09-30 The Procter & Gamble Company Personal care composition
US11819474B2 (en) 2020-12-04 2023-11-21 The Procter & Gamble Company Hair care compositions comprising malodor reduction materials
WO2022197295A1 (en) 2021-03-17 2022-09-22 Milliken & Company Polymeric colorants with reduced staining
US12409125B2 (en) 2021-05-14 2025-09-09 The Procter & Gamble Company Shampoo compositions containing a sulfate-free surfactant system and sclerotium gum thickener
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
WO2023017794A1 (en) 2021-08-10 2023-02-16 株式会社日本触媒 Polyalkylene-oxide-containing compound
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules
US12458575B2 (en) 2021-12-09 2025-11-04 The Procter & Gamble Company Sulfate free personal cleansing composition comprising effective preservation
WO2023114932A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114936A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114939A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023116569A1 (en) 2021-12-21 2023-06-29 Novozymes A/S Composition comprising a lipase and a booster
WO2023247664A2 (en) 2022-06-24 2023-12-28 Novozymes A/S Lipase variants and compositions comprising such lipase variants
WO2024020445A1 (en) 2022-07-20 2024-01-25 Ecolab Usa Inc. Novel nonionic extended surfactants, compositions and methods of use thereof
WO2024050343A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Subtilisin variants and methods related thereto
WO2024050346A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Detergent compositions and methods related thereto
WO2024050339A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Mannanase variants and methods of use
WO2024102698A1 (en) 2022-11-09 2024-05-16 Danisco Us Inc. Subtilisin variants and methods of use
WO2024121058A1 (en) 2022-12-05 2024-06-13 Novozymes A/S A composition comprising a lipase and a peptide
WO2024121057A1 (en) 2022-12-05 2024-06-13 Novozymes A/S A composition for removing body grime
WO2024163584A1 (en) 2023-02-01 2024-08-08 Danisco Us Inc. Subtilisin variants and methods of use
WO2024186819A1 (en) 2023-03-06 2024-09-12 Danisco Us Inc. Subtilisin variants and methods of use
WO2025085351A1 (en) 2023-10-20 2025-04-24 Danisco Us Inc. Subtilisin variants and methods of use
WO2025133314A1 (en) 2023-12-21 2025-06-26 Heubach Holding Switzerland Ag (Ltd) Polymeric dyes with enhanced biodegradability containing polycarboxylic acids, amino acids, polyamino acids and/or peptide building blocks
EP4617327A1 (en) 2024-03-13 2025-09-17 Heubach Holding Switzerland AG (Ltd) Polymeric dyes with enhanced biodegradability containing saccharide or polysaccharide building blocks

Also Published As

Publication number Publication date
EP1135392A2 (en) 2001-09-26
WO2000032601A3 (en) 2000-10-05
AU2026100A (en) 2000-06-19
JP2002531457A (en) 2002-09-24
CA2348893A1 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
WO2000032601A2 (en) Process for preparing cross-bridged tetraaza macrocycles
EP0648211A1 (en) Synthesis of 1,4,7-triazacyclononane derivatives
EP0408340B1 (en) Ruthenium-optically active phoshine complex useful as catalyst
EP0034480A2 (en) Alkylation of amines
EP1687310B1 (en) Method for the catalytic production of hydrocodone and hydromorphone
EP0403188A2 (en) A compound of 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl and catalytic complexes thereof
US7321038B2 (en) Method for the catalytic production of hydrocodone and hydromorphone
AU2003290629B2 (en) Method for the catalytic production of hydrocodone and hydromorphone
WO1995002567A1 (en) Catalytic asymmetric reduction of trisubstituted olefins and enamines
US5159093A (en) Iridium-optically active phosphine complex and process for producing optically active alcohols using the same
US7399858B2 (en) Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof
US4954466A (en) Recovery of cobalt catalyst values
CN1055463C (en) Process for the manufacture of guanidines
US4076724A (en) Polycyclic macrocyclic compounds
WO2000029413A1 (en) Process for preparing cross-bridged tetraaza macrocycles
MX2007011752A (en) Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof.
JP4070444B2 (en) Process for producing unsaturated amines
CN112675920A (en) Mono-chiral center catalyst, preparation thereof and method for catalytically synthesizing chiral alcohol compound and chiral alpha-allyl alcohol
JP2981621B2 (en) Biphenyl bisphosphine complex
AU2004319925B2 (en) Method for the catalytic production of hydrocodone and hydromorphone
WO1997037965A1 (en) Preparation of substituted aromatic amines
JP2002508777A (en) Method for aminating mononuclear aromatic compounds and polynuclear compounds having at least one aromatic ring in the presence of a palladium complex salt catalyst
US6229035B1 (en) Preparation of substituted aromatic amines
JP4359440B2 (en) Method for producing nitriles
JPS6293273A (en) Production of indole

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2348893

Country of ref document: CA

Ref country code: CA

Ref document number: 2348893

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09831198

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1999963923

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 585243

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1999963923

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWR Wipo information: refused in national office

Ref document number: 1999963923

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999963923

Country of ref document: EP